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ABSTRACT 
 
Pancratistatin is a naturally occurring Amaryllidaceae alkaloid isolated from the bulbs of 
Pancratum littorale.  Pancratistatin has been shown to be capable of inducing apoptosis 
in several cancer cell lines.  Although the biochemical mechanism for the apoptosis is not 
yet well known, results suggest that pancratistatin could be a very effective non-toxic 
alternative for anticancer therapy.  Nevertheless, further analysis of pancratistatin has 
been hindered by bioavailability and solubility problems.  The aim of this research is to 
find a viable synthesis of pancratistatin, after which an array of analogues containing a 
variety of aromatic units can be proposed.   
 
The synthesis of pancratistatin began using carbohydrate chemistry for the initial 
preparation of the key stereochemical cyclitol ring C of pancratistatin.  Chapter 2 of this 
dissertation describes the syntheses of the suitable glucose derived compounds.  
Previously established carbohydrate chemistry was used to prepare (3aR,5S,6R,6aR)-2,2-
dimethyl-6-[(phenylmethyl)oxy]tetrahydrofuro[2,3-d][1,3]dioxole-5-carbaldehyde 104.  
The aldehyde 104 was used to prepare the nitroalkene 105 and the enoate 106.  The 
Henry reaction was used to synthesize the nitroalkene (3aR,5R,6R,6aR)-2,2-dimethyl-5-
[(E)-2-nitroethenyl]-6-phenylmethyl)oxy]tetrahydrofuro[2,3-d][1,3]dioxole 105. 
Similarly, a Horner-Wadsworth-Emmons reaction was utilized to prepare the enoate 
methyl (2E)-3-{(3aR,5R,6R,6aR)-2,2-dimethyl-6-[(phenylmethyl)oxy]tetrahydrofuro[2,3-
d][1,3]dioxol-5-yl}prop-2-enoate 106. 
 
In Chapter 3 of the dissertation, the previously prepared nitroalkene 105 and enoate 106 
are used in an array of conjugate addition reactions.  The first method utilized 
organocuprate conjugate addition, while the second method adopted a rhodium(I)-
catalyzed conjugate addition.  A variety of aromatic substituents were used as the 
nucleophilic partners namely, phenyl, dioxolylphenyl, benzodioxine, and 
trimethoxyphenyl. 
 
 ii
In Chapter 4 of the dissertation, using only the phenyl and dioxolylphenyl substituted 
compounds, deprotection of the acetonide group was attempted.  This was followed by 
several attempts at ring closure and acetylation reactions, unfortunately without success 
and no further progress concerning this synthetic strategy could be made. 
 
Finally, in Chapter 5 of the dissertation a summary of the results observed for the 
research project was made.  This was followed by the experimental data for the reactions 
investigated during the project (Chapter 6), and a brief appendix. 
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CHAPTER 1:  INTRODUCTION 
 
1.1. Amaryllidaceae alkaloids 
 
 
The Amaryllidaceae alkaloids constitute an important class of naturally occurring 
compounds which have interesting biological and medicinal properties1 that have dated 
back to the time of the ancient Greeks.  The medicinal value of the extracted oils of the 
daffodil, Narciclassus poeticus L., in the treatment of illnesses related to cancer was 
already known to the Greek physician Hippocrates of Cos; however, it was not until 1877 
that the first Amaryllidaceae alkaloid, lycorine 1, was isolated (Figure 1).2  Today the 
structurally diverse family compromises more than 100 alkaloids.3,4 
 
N
O
O
OH
HO
1  
 
Figure 1. The first isolated Amaryllidaceae alkaloid, lycorine 1. 
 
Structurally, the Amaryllidaceae alkaloids can be sub-divided into three major skeletal 
arrangements; namely, the lycorane, crinane or the galanthamine cores (Figure 2), 
although more complex modifications have been noted.5  However from a biological and 
thus potentially medicinal perspective, the modified lycorane-type alkaloids with a 
phenanthridone core (Figure. 3), such as, narciclasine 2, lycoricidine 3, pancratistatin 4, 
and 7-deoxypancratistatin 5 are up to ten times more active than alkaloids of the 
remaining two sub-classes, such as galanthamine 6, ungeremine 7 and hippeastrine 8 as 
depicted in Figure 4.  Understandably, the former set of compounds are therefore 
discussed and studied far more comprehensively in the literature. 
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N N
NMe
Lycorane-type Crinane-type Galanthamine-type  
 
Figure 2.  Biosynthetic origin of the Amaryllidaceae alkaloids 
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Figure 3.  Phenanthridone family of alkaloids. 
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Figure 4.  Amaryllidaceae alkaloids showing interesting structural properties. 
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Narciclasine 2 was first isolated in 1968 from the bulbs of Lycoris radiate.  The cytotoxic 
activities of narciclasine 2 was also reported and it was found to inhibit the cytotoxic 
properties of calproctin, a protein found in neutrophils and in extracellular media during 
inflammation.6  These natural products have also been shown to inhibit ribosomal protein 
biosynthesis and to promote apoptosis and are thus valuable tools and medicinally 
important leads in the treatment of cancer.7 
 
Narciclasine 2 has been found to be highly active against several cancer cell lines, most 
notably murine P388 lymphocytic leukemia and human cancer cell lines such as pancreas 
BXPC-3, breast MCF-7, CNS SF-268, lung NCL-H460, colon KM-20L2, and prostate 
DU-145.8-11  It is believed that narciclasine 2 inhibits the formation of peptide bonds on 
eukaryotic ribosomes.  The activity of lycoricidine 3 and 7-deoxypancratistatin 5 are 
some 100-fold lower, and it is thought that the absence of the phenolic hydroxyl group is 
responsible for the diminished activity.12  Other medicinally useful physiological effects 
include antiviral and antimalarial activities,4 as well as the treatment of neurogenerative 
diseases such as Alzheimer’s5 and immunostimulatory, acetylcholinesterase inhibition.4 
 
The future of the alkaloids as therapeutic agents depends on their availability, because the 
isolation of large quantities of the alkaloids from the natural source is not practical.  Thus 
there is a strong case for the development of syntheses or semi-syntheses of these 
alkaloids, their derivatives, and the development of potential prodrugs.3 
 
Pancratistatin 4, shown in Figure 3, will be discussed further in the next chapter owing to 
its direct chemical and biological importance to the proposed project. 
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1.2. Pancratistatin 
 
Although the mechanism of action of narciclasine has been studied more thoroughly, the 
most promising activity resides with pancratistatin.2,13  Pancratistatin was isolated by 
Pettit and co-workers in 1984 from the bulbs of Pancratum littorale.14  However, clinical 
development of the natural product has been hampered as a consequence of the minute 
quantity of material available from its isolation (6.5 g of pancratistatin were extracted 
from 45 kg of bulbs).2,15  As a result, it has been an important task to develop an efficient 
synthesis for the preparation of pancratistatin.   
 
NH
O
O
O
HO OH
OH
OH
OH
4
1
2 3
4
4a
10b
7
10a
6
A B
C
56a
10
 
 
Figure 5.  Structure of (+)-pancratistatin 
 
While pancratistatin 4 is not a large molecule, it contains a number of complex structural 
elements, when combined make it a formidable target molecule to synthesize.16,17  The 
overall structure is comprised of six contiguous stereogenic centres in the C ring of the 
phenanthridone skeleton (Figure 5).17,18  The cyclitol ring also contains further 
stereochemistry, in addition to the requirement for the stereo-controlled installation of the 
four surrounding hydroxyl groups.  Due to the cyclitol’s (C ring) interactions with ring B, 
the benzylic stereocentre, C10b, which is attached to the pentasubstituted aromatic ring 
A, forms a trans-fused BC ring system with C4a.  This has shown to be a particularly 
difficult synthetic challenge because of the lactam in ring B contributing to a highly 
strained system due to its trans-fused relationship with ring C.  This distorts the planarity 
created by the four atoms in the sp2-hybridization state (C10a, C6a, C6 and N5).4,16,17,19,20  
Furthermore, pancratistatin 4 is remarkably insoluble in various organic solvents, as well 
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as water (53μg/ml),21 making the search for efficient analogues of pancratistatin 4 
necessary.22,23 
 
1.3. Biomedicinal aspects of pancratistatin 
 
1.3.1. Structural importance leading to the activity of pancratistatin 
 
The structural skeleton of pancratistatin 4 has revealed an abundance of information 
about its activity. Through the addition or the removal of certain groups on the 
pancratistatin 4 backbone, relevant information about the efficiency of the biological and 
medicinal activity of pancratistatin has been recorded.  
 
NH
O
O
O
HO OH
OH
OH
OH
1
2 3
4
4a
10b
7
10a
6
A B
C
56a
10
variable
essential
essential
4
 
 
Figure 6.  Structural and functional requirements for the minimum pharmacophore of 
pancratistatin and its congeners. 
 
For instance, the absence of the phenolic hydroxyl at C7, as seen in 7-deoxypancratistatin 
5, leads to a 10-fold decrease in activity, so that only moderate cytotoxicity is observed.  
In addition, the donor-acceptor hydrogen bond pairing of 7-OH and the carbonyl at C6 
has been found to demonstrate some successful binding to DNA domains.24-27   
 
The aminoinositol moiety is probably the structural element responsible for the antiviral 
activity reported for pancratistatin.  The oxygenated phenathridone unit is thought to 
result in DNA intercalation, which can also be supported by the fact that cis-fused 
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derivatives of pancratistatin are entirely inactive, perhaps due to their three-dimensional 
structures adopting a more concave appearance.  These aminoinositol moieties should 
thus remain essentially intact, except for minor variations of substituents, functionalities, 
and configuration at C1.25,26  McNulty et al.25 discovered that the hydroxyl group at C4 is 
required in conjunction with either or both of the hydroxyl groups at C2 and C3, thus 
being important features in the minimum pharmacophore (Figure 7).  Similarly, 
Hakansson15 and Rinner28 have tested a series of deoxy analogues of the aminocyclitol 
part (ring C) against a variety of the US National Cancer Institute (NCI) panel of cancer 
cell lines, showing a highly characteristic cytotoxicity profile of the compounds with a 
pronounced activity towards the melanoma panel of cell lines, as well as a number of in 
vivo experimental cancer systems. These results have led to the conclusion that at least 
two hydroxyl groups are necessary for activity on the cyclitol ring, although the activity 
is usually somewhat reduced from the original pancratistatin model.  Conversely, 
Hudlicky et al.29 established that the minimum requirement for activity of the cyclitol 
ring requires a 2,3,4-triol pattern that is found in all active constituents (Figure 8).  
 
NH
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OH
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Figure 7.  McNulty’s systematic refinement of the pancratistatin pharmacophore.25 
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OH
2 3
4
 
 
Figure 8.  Hudlicky’s 2,3,4-triol requirement for activity  of pancratistatin analogues.29 
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Another essential feature for the activity of panctratistatin 4, is the trans-fused BC 
junction formed by the lactam.15,25,26  The importance of the ring B has been addressed, 
and it has been shown that open ring analogues (i.e. with absent C10a-C10b bond) or an 
ester group as in 9 (Figure 9) in lieu of the amide were both devoid of anticancer 
activity.30  Recent work has also been accomplished pertaining to the aromatic group of 
the pancratistatin compound, and some indole mimics of pancratistatin, such as structure 
10  in Figure 9, have been shown to possess borderline activity against one cancer cell 
line.29 
 
O
O
O
O
OH
OH
OH
OH
NH
O
OH
OH
OH
HO
N
H
9 10  
 
Figure 9.  Examples of pancratistatin analogues. Inactive lactone 9 and borderline active 
indole mimic 10. 
 
1.3.2. Anticancer biochemical pathway of pancratistatin  
 
Cancer cells are characterized by an accelerated growth and a disrupted apoptotic 
mechanism.10  One of the focus points when developing anticancer drugs is to target the 
biochemical pathway which will induce apoptosis in cancerous cells.9   
 
Apoptosis, or programmed cell death, is a physiological process that is essential in 
normal development and tissue homeostasis as it removes cells that are no longer needed 
or are potentially harmful.  Necrosis is another distinct category of the cell death process 
and is defined by cell and organelle swelling, leading to the disruption of the cell 
membrane and cell lysis.31 
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During the process of apoptosis cell shrinkage and nuclear condensation occurs and the 
eventual non-traumatic removal of the affected cells proceeds via phagocytosis.9,10  
Apoptosis is the counterpart and counterbalance to mitosis in cell population 
determination.  Apoptosis is usually triggered by an apogen, and complex patterns of cell 
signalling and specific gene expression are involved in the control of a cell’s fate.  
Exposure to an apogen significantly increases apoptotic cell loss during homeostatic 
processes as well as acute or chronic toxicities.32  Alternately, disruption of the apoptotic 
pathway may lead to autoimmunity, neurodegenerative disorders, and acquired immune 
deficiency syndrome.  This could result in pathological accumulation of abnormal cells 
(tumours), and thus all types of cancer.10,32   
 
Mitochondria play a key role in the apoptotic mechanism by releasing caspase-
independent death effectors, and causing the loss of essential mitochondrial functions.  
During apoptosis, the outer mitochondrial membrane becomes permeable, allowing 
certain proteins such as cytochrome C, Apaf-1 and pro-caspase 9 to activate caspase 9, 
which will initiate the induction of apoptosis.9,10,31 
 
The currently used anticancer treatments, including chemotherapeutics and 
radiotherapies, are capable of triggering apoptotic cell death in cancer cells by causing 
DNA damage.  Unfortunately there is a degree of risk involved in these treatments, 
because of the consequence of toxicity to normal cells due to the fact that cancer cells 
tend to differ from normal cells only in the DNA replication mechanism and rate of 
proliferation.  There are very few anticancer drugs that are capable of targeting receptors 
or other components of the cell without producing any genotoxic effects.  Current 
therapies thought to be non-genotoxic include paclitaxel and tamoxifen.  However, 
although it was believed that paclitaxel induces non-genotoxic apoptosis by stabilizing 
tubulin, it has recently been shown to be genotoxic.9,10 
 
Pancratistatin 4 has been shown to be capable of effectively inducing apoptosis in several 
cancer cell lines, including lymphoma cells (Jurkat),8-11,33 breast cancer cells 
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(MCF7),9,10,28 and rat hepatoma cells (5123 tc),5,9,10,31 within a short period of time at a 
very low concentration. 
 
Although the biochemical mechanism by which pancratistatin 4 induces apoptosis in 
cancer cells is still unknown, the involvement of caspase-3 and the plasma membrane 
proteins (phosphatidyl serine) in the induction phase of apoptosis, indicate that 
pancratistatin 4 does not cause DNA double-strand breaks or DNA damage prior to the 
execution phase of apoptosis in cancer cells.5,9,10 
 
1.3.3. Antiparasitic biochemical pathway of pancratistatin  
 
The antiparasitic effect of pancratistatin 4 was tested on a mammalian cell line infected 
with Encephalitozoon intestinalis, a microsporidian causing intestinal and systemic 
infection, such as nephiritis, bronchitis and lytic mandibular lesions in 
immunocompromised patients.  Microsporidia are widespread intracellular parasites, 
apparently able to invade any cell in animals and humans.34 
 
Many parasites share a strategy for transfer between different hosts, whereby an 
obligatory non-dividing stage precedes the next distinct proliferative phase.35  The life 
cycle of Encephalitozoon intestinalis consists of two successive developmental 
sequences, merogony and sporogony, which take place in a parasitophorous vacuole 
within the host cells.  Merogony consists of a proliferation stage, followed by multiple 
divisions, until sporonts are formed.  At this point sporogony occurs, whereby additional 
division occurs until the final spore is formed.  The spores are mononucleated and it has 
been speculated that the regulation of this development is linked to the control of the cell 
cycle.  These parasitic cell cycles are usually complex and involve a series of specific 
developmental stages in insect or mammalian hosts.34   
 
The antiparasitic effect was evaluated in two ways, firstly, by counting the number of 
parasitophorous vacuoles detected by immunofluorescence, and secondly, by using a 
specific group of protein kinases, the cyclin-dependent kinases (CDKs).  These enzymes 
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have been shown to be crucial regulators of the timing and co-ordination of the 
eukaryotic cell cycle.35  Their activity is regulated by their phosphorylation status and by 
the association with negative (cyclin kinase inhibitors) and positive (cyclins) regulators, 
and by intracellular translocations.  Thus, the importance of the CDK enzymes in the 
multiplication and development of eukaryotes represents an attractive potential target for 
antiparasitic chemotherapy.34,35   
 
The results showed a significant reduction of the microspridian infection.  It was found 
that pancratistatin 4 inhibited the infection without affecting the host cell; furthermore, it 
was observed that pancratistatin 4 was able to block the development of the sporonts and 
spores rather than the entry of the parasite into the host cell, suggesting that pancratistatin 
4 acted as an inhibitor and was blocking a specific phase of cell division of the parasite.34 
 
1.4. A review of previous syntheses of pancratistatin and pancratistatin analogues  
 
The synthetic pathway to the complete synthesis of pancratistatin requires the adaptation 
of various tactical strategies in order to combat the difficulties with its structural 
complexity.  In order to account for the entire synthesis, certain components need to be 
considered, namely, the starting material used, the strategy for achieving the asymmetric 
synthesis if only the (+)-enantiomer of the natural product was prepared, the installation 
of stereocentres into ring C, a strategy for the closure of ring B and the regioselective 
introduction of the substituents in the pentasubstituted aromatic ring A.16  In this section 
an evaluation of the previous syntheses of pancratistatin 4 will be discussed. 
 
1.4.1. Danishefsky and Lee 19  
 
Danishefsky and Lee accomplished the first total synthesis of racemic pancratistatin, 
publishing a full paper in the Journal of the American Chemical Society in 1989.19  The 
synthesis commenced with the aromatic substituent (ring A) from the tri-substituted 
pyrogallol 11 (Scheme 1).  This compound was treated with triethyl orthoformate to give 
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the orthoester 12, which protected the diol while the remaining hydroxyl group 
underwent a carbamoylation to yield compound 13.  The diol was then unmasked to give 
14 and the installation of the methylenedioxy moiety could then afford compound 15.  A 
rearrangement reaction facilitated by a Snieckus directed ortho-metalation was then 
employed to transform the carbamate 15 into the corresponding amide 16.  The tetra-
substituted compound 17 then underwent a further metalation and a quench with 
dimethylformamide (DMF) to provide the required aldehyde 18 in a 70% yield.  Thus the 
components of the aromatic ring (ring A) in pancratistatin could be introduced 
regioselectively. 
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Scheme 1.  (i) (OEt)3CH, PhH, reflux, Amberlyst-15 (cat), 86%; (ii) Et2NCOCl, NaH, 
DMAP, THF; (iii) p-TsOH, MeOH, 86% from 12; (iv) CH2Br2, K2CO3, CuO, DMF, 
70%; (v) s-BuLi, TMEDA, DMF, THF, 58%; (vi) TBSCl, imidazole, CH2Cl2, 86%; (vii) 
s-BuLi, TMEDA, DMF, THF, 70%; (viii) CH2=CHCH2MgBr, Et2O , 92%. 
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The formation of ring C proceeded from the aldehyde with the addition of an allyl 
Grignard reagent to 18, followed by the dehydration of the hydroxyl group from 
compound 19 to give the diene 20 as shown in Scheme 2.  The C ring could then be 
formed by the Diels-Alder cycloaddition of the diene with the β-nitrovinyl sulfone 21, to 
form the cycloadduct 22 in 96% yield.  It was necessary to remove the TBS group 
(compound 23) prior to iodolactonization as attempted generation of the halolactone 
failed with the protecting group because of steric hindrance.  The free phenol 24 then 
reacted to give the iodolactone product 25 in an 80% yield.  This transformation initiated 
the cis-C10b-C1 relationship between ring A and ring C of pancratistatin.  The double 
bond was then dihydroxylated using catalytic osmium tetroxide (OsO4) and N-
methylmorpholine-N-oxide (NMO) to give the single stereoisomer 26 in 90% yield. 
 
Before installation of the C2-C3 functionality it was necessary to prepare for the 
regiospecific reductive elimination of the C4a and C4 heteroatoms.  Thus, compound 26 
was reacted with 2-acetoxyisobutyryl bromide, to convert the cis-C4a-C4 diol into trans-
bromoacetate.  This proved somewhat complicated as it afforded the bromoacetate 28 in 
63% yield, but also gave rise to a significant amount (25%) of the allylic isomer 27 
(Scheme 3).  However the dihydroxylation of the C2-C3 double bond did indeed occur of 
the less hindered α-face of the molecule, due to the presence of the C1- and C4-
substituents blocking the β-face, to produce the cis diol 29 with 88% yield  
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Scheme 2.  (i) MsCl, Et3N then DBU, CH2Cl2, 54%; (ii) (E)-O2N-CH=CH-SO2Ph 21, 
CHCl3, 96%, (iii) Bu3SnH, AIBN, PhMe, 72%; (iv) Bu4NF, THF, 80%; (v) (Bu3Sn)2O, 
PhMe, I2, 67%; (vi) BnBr, Ag2O, DMF, 85%; (vii) OsO4, NMO, THF, H2O, CH2Cl2, 
90%; (viii) DBU, PhH, 88%. 
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Scheme 3.  (i) 2-Acetoxyisobutyryl bromide, MeCN, 88%; (ii) OsO4, NMO, THF, 88%. 
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The cis-diol 29 underwent various protections and dehydrations until the reaction with 
sodium hydride (NaH) and trichloroacetonitrile (CCl3CN) afforded the sought after 
imidate 30 in a 74 % yield.  The focus now remained on the introduction of the C4a- α-
amino moiety, which relied upon an Overman imidate-Claisen rearrangement, which took 
place when the imidate 30 was heated under vacuum, to produce 31 in 56% yield 
(Scheme 4).  With re-exposure to osmium tetroxide (OsO4) and N-methylmorpholine-N-
oxide (NMO), the remaining olefin was dihydroxylated, and lactone 32, better known as 
the “Danishefsky lactone,” was formed.  This was treated with potassium carbonate in 
methanol for the removal of the tricholoroacetamide and hydrolysis of the lactone to give 
the intermediate 33, which cyclized into the complete phenanthridone ring 34 with the aid 
of dicyclohexylcarbodiimide (DCC).  Finally, hydrogenation of the two benzyl groups 
provided racemic pancratistatin 4 in a total of 29 steps.  Therefore, although the 
pyrogallol (11, Scheme 1) provided a reasonably inexpensive starting compound, which 
already contained three oxygen-bearing groups from ring A of pancratistatin 4, the 
synthesis proved to be somewhat lengthy and demanding. 
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Scheme 4.  (i) (Bu2Sn)2O, PMBBr, Bu4NI, 84%; (ii) BnBr, Ag2O, DMF, 95%; (iii) DDQ, 
H2O, CH2Cl2, 75%; (iv) Zn, HOAc, H2O, 81%; (v) NaH, CCl3CN, THF, 74%; (vi) 100°C, 
high vacuum, 56%; (vii) OsO4, NMO, THF, H2O, 75%; (viii) K2CO3, MeOH, CH2Cl2; 
(ix) DCC, CH2Cl2, 82% (over two steps); (x) H2, Pd(OH)2/C, EtOAc, 90%. 
 
1.4.2. Hudlicky and co-workers2,12,36 
 
In 1995, Hudlicky et al. were able to achieve the first asymmetric synthesis of (+)-
pancratistatin, with specific rotation [α]26D of +41.0 (c 1.0, DMSO).  Enatiomerically pure 
diol 36 were prepared by the oxidation of halobenzene 35 with whole cells of P. putida 
39/D or recombinant E. coli JM109.  Hudlicky’s group successfully employed a trans-
aziridine ring opening method in order to set into place the nitrogen component of the 
pancratistatin C ring.  Initially, the aziridine 43 was prepared as shown in Scheme 5.  The 
two double bonds (in 36) have different reactivity patterns, making selectivity favourable, 
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hence the formation of bromohydrin 36.  The azide 39 was then formed, which was 
subsequently mesylated to afford compound 40, which was followed by a reduction with 
lithium aluminium hydride (LiAlH4) to afford the aziridine 41, which in turn could be 
tosylated to give compound 42.  It was later found that the synthesis of the aziridine could 
be reduced to a far more effective approach if the Yamada iodonium ylide (step ix, 
Scheme 5) was employed from compound 37.12   
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Scheme 5.  (i) P. putida 39/D; (ii) DMP, p-TsOH, 85%; (iii) NBS, DME, H2O; (iv) NaN3, 
DMSO, 87%; (v) MsCl, Et3N, CH2Cl2; (vi) LiAlH4, THF; (vii) TsCl, Et3N, CH2Cl2, 
30.7% (from diol 36); (viii) Bu3SnH, AIBN, PhMe, 78%; (ix) PhI=NTs, MeCN, 
Cu(acac)2, 54%. 
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The aromatic ring A of pancratistatin 4 was then prepared by a directed ortho-metalation 
with the aid of higher order cuprates 47 (Scheme 6).  This required the starting material, 
piperonic acid 44, to first undergo an amidation to form compound 45 in 71% yield.  The 
C7 hydroxy group of pancratistatin 4 was then installed by an ortho-lithiation with s-
BuLi/TMEDA, boration with trimethylborate (B(OMe)3) and subsequent oxidation with 
hydrogen peroxide (H2O2) to give compound 46.  An investigation of the higher order 
cuprates showed that lithium dimethylcyanocuprates gave the syn-1,4-addition product, 
while lithium diphenylcyanocuprates gave the anti-1,2-addition product.  Therefore, 
when the nucleophilic SN2 ring opening of the vinylaziridine 43 was performed, it was 
found that the use of the higher order cuprate 47 gave the necessary anti-1,2-addition 
product 48 in 75% yield. 
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Scheme 6.  (i) SOCl2, Me2NH, 71%; (ii) s-BuLi, TMEDA, B(OMe)3, H2O2, 80%; (iii) 
TBSCl, 95%; (iv) s-BuLi, TMEDA, THF, CuCN; (v) BF3.Et2O, 75%. 
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At this point the synthesis became somewhat complicated, as it was observed that 
compound 48 existed as α and β atropisomers.  Boc protection then formed a mixture of 
atropisomers 49a and 49b in 68% yield (Scheme 7).  The mixture of atropisomers was 
detosylated using Na/anthracene/DME to afford compounds 50 and 51 in a combined 
yield of 82%.  The α-form 51 could be further desilylated to give the β-form 50 in 93% 
yield.  The benzamide 50 was then reduced to the aldehyde 52, using sodium bis(2-
methoxyethoxy)aluminium hydride (SMEAH)/morpholine and the free alcohol was again 
protected as the benzyl ether 53.  The aldehyde 52 was then oxidized to the acid 54, 
followed by methylation using diazomethane which afforded the methyl ester 55, 
followed by deprotection of the acetonide 56, and hydroxyl-directed epoxidation with 
tert-butyl hydroperoxide and vanadyl acetylacetonate (t-BuOOH/VO(acac)2) to provide 
the epoxy diol 57.  Finally, cyclization occurred with refluxing water containing a 
catalytic amount of sodium benzoate.  Under these conditions the Boc amide underwent a 
retro-ene reaction, thus liberating the amine for cyclization.  The benzyl group was finally 
removed by hydrogenation to give pancratistatin 4.  Overall, the target material was 
reached in 14 steps and 2% total yield. 
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Scheme 7.  (i) s-BuLi, (BOC)2O, THF, 68%; (ii) Na, anthracene, DME, 82% (combined 
yield from 49 and 50); (iii) TBAF, THF, 93%; (iv) SMEAH, morpholine, THF, 72%; (v) 
BnBr, K2CO3, DMF, 83%; (vi) NaClO2, KH2PO4, t-BuOH, H2O, 2-methyl-2-butene, 
100%; (vii) CH2N2, Et2O; 98%; (viii) AcOH, H2O, 73%; (ix) t-BuO2H VO(acac)2, PhH, 
53%; (x) H2O, BzONa(cat), 51%; (xi) H2, Pd(OH)2/C, EtOAc. 
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1.4.3. Paulsen and Stubbe37,38 
 
The approach by Paulsen and Stubbe does not directly involve the synthesis of 
pancratistatin, but rather (+)-lycoricidine 3. However several key chemistry procedures 
used in their synthesis have been adapted for the purpose of this MSc project (see Section 
1.5.3).   
 
One of the major problems with many approaches to the formation of ring C in 
pancratistatin 4 and other Amaryllidaceae alkaloids that exhibit similar chemical 
properties and appearance, is the insertion of the oxygen functionalities as well as the 
tendency of certain adducts toward aromatization.  Paulsen solved the problem of 
oxygenation by starting his synthesis with D-glucose 58 and converting it into the 
unsaturated nitro olefin 60 to which the aryl fragment 61 could be added (Scheme 8).  The 
conjugate addition of the aromatic group 59 to the nitroalkene 60 was not very strongly 
selective and this provided the two diastereomers 62 and 63 in an overall yield of 77%.   
 
The mixture of diastereomers 62 and 63 (Scheme 8) was reacted with acetic acid to 
expose cyclic hemiacetal intermediates, which were then deprotonated at the α-C to the 
nitro with the mild base, potassium carbonate.  At this point in the synthesis the products 
could be separated, by forming the “Paulsen-Danishefsky” lactone 64 in a low yield of 
34%.  The lactone 64 was then hydrogenated with H2/Pd to give amino alcohol 65, and 
reacted with potassium carbonate to induce the formation of the lactam ring and thus by 
default (+)-7-deoxypancratistatin 5.  However, Paulsen’s aim was to synthesize (+)-
lycoricidine 3, so the C1 hydroxyl group was dehydrated, which in turn caused the C10b 
centre to lose its stereochemistry.  Thus when Paulsen published his asymmetric synthesis 
of (+)-lycoricidine 3 from D-glucose in 1983, it was effectively also the first synthesis of 
(+)-7-deoxypancratistatin 5, even though this compound would only be recognized as a 
natural product in 1984. 
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Scheme 8.  (i) CH3NO2, Et3N, Et2O, 88% (mixture of epimers); (ii) MeSO2Cl, Et3N, 
Et2O, 76%; (iii) Br2 ; (iv) i-PrOH, conc. H2SO4, 56%; (v) CH2Cl2, 77% combined; (vi) 
AcOH, PhCH3; (vii) K2CO3, MeOH, 34% (over two steps); (viii) H2/Pd, MeOH; (ix) 
K2CO3, MeOH, 72%; (x) SOCl2/Pyridine, 88%. 
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Scheme 8 shows the synthetic route when using diastereomer 63 only, as it is the apparent 
compound for accomplishing the synthesis of (+)-lycoricidine 3.  However, the products 
of diastereomer 62 have been shown in Scheme 9.  Once the L-ido-compound 62 was 
reacted with acetic acid and potassium carbonate, and cyclized into the acetylated form of 
the lactam, the two inositol-type products, in the scyllo 66 and myo 67 conformations 
were produced.  This occurred due to the change in conformation of the C4 hydroxyl 
group from equatorial to axial.  The overall change to the product, which is itself an 
adduct of 7-deoxypancratistatin 5, showed changes in stereochemistry, compared to its 
parent structure at the C10b stereocentre and the C4 stereocentre. 
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Scheme 9.  Key stereochemical changes in diastereomer 62. 
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1.4.4. Trost and co-workers12,39 
 
In 1995 Trost et al. achieved the second asymmetric synthesis of pancratistatin 4 by using 
the method of palladium-catalyzed desymmetrization.  Benzoquinone was converted into 
a key conduritol derivative, which was treated with n-BuLi and methylchloroformate to 
form the symmetric dicarbonate 68 shown in Scheme 10. The meso conduritol 68 was 
then subjected to the key desymmetrization process in the presence of the azide 
nucleophile, trimethylsilyl azide, the palladium complex, and a C2-symmetric catalyst A, 
to give the homochiral carbonate 69.  The aryl group was then introduced by a regio- and 
diastereo-controlled SN2 cuprate-controlled Grignard addition to give compound 70.   
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Scheme 10.  (i) 0.5% (p-C3H7PdCl)2, 0.75% A, TMSN3, 82%; (ii) ArMgBr, CuCN; (iii) 
cat. OsO4, NMO.H2O, 62% from 69; (iv) TESOSO2CF3, 2,6-lutidine, 100%; (v) NBS, 
75%; (vi) (CH3)3P, H2O, COCl2; (vii) t-BuLi, 65% from 70; (viii) TBAF; (ix) SOCl2, 
pyridine, cat. RuCl3.H2O, NaIO4, 72% from 72; (x) PhCO2Cs, H2O, cat. H2SO4, 85%; (xi) 
MeOH, K2CO3, LiI, 85%. 
 
At this point in the synthesis both the A and C rings are in place, and some of the most 
necessary components, such as the nitrogen substituent and three hydroxyl groups are 
present.  The remainder of the synthesis required a regioselective bromination of the 
group ortho to the methoxy C6a using N-bromosuccinimide (NBS) to afford compound 
71, followed by the formation of the isocyanate intermediate 72 from a 
trimethylphosphine [(CH3)3P] and phosgene (COCl2) reaction.  This compound could 
then be cyclized to form the lactam 73, which underwent various protections and 
deprotections to achieve the correct stereochemical inversions of the hydroxyl groups to 
 24
Chapter 1                                                                                                          Introduction 
 
finally achieve the synthesis of pancratistatin 4.  The synthesis was accomplished in 19 
steps with an overall yield of 8% from benzoquinone. 
 
1.4.5. Haseltine and co-workers40 
 
Haseltine and co-workers reported a total synthesis of (+)-pancratistatin 4 in 1997.  As 
with the synthesis reported by Trost and co-workers39 their approach utilized 
benzoquinone as a starting material, which eventually underwent a retro Diels-Alder to 
afford a protected conduritol, similar to the intermediates utilized by Trost’s group for 
their synthesis.  An enzymatic acetylation using P30 lipase led to desymmetrization of the 
conduritol to form the enantiopure acetate, which was exchanged with tert-
butyldimethylsilyl (TBS) to give product 75 as shown in Scheme 11.  The aromatic 
substrate 74 was prepared from piperonal and contained the methylenedioxy moiety and 
the C6a bond.  The construction of the C10b-C10a bond was accomplished using the 
aromatic group 74 with the meso conduritol 75 by an intramolecular elecrophilic aromatic 
SN2 substitution to give the coupled product 76.  Introduction of the C7 hydroxyl into 
ring A, and the stereoselective cylization of the C10a-C10b bond created some setbacks 
in the synthesis; however the Danishefsky-type lactone, intermediate 77 (Section 1.4.1, 
scheme 4) was synthesized, which led to convergence for the remainder of the synthesis.  
This includes the installation of the stereocentres by a syn-specific Overman 
rearrangement that resulted in the introduction of the C4a nitrogen. 
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Scheme 11. (i) NaH, Bu4NI, TBAF, 83%; (ii) Tf2O, 2,6-lutidine or 2,6-di-t-Bu-pyridine, 
73%; (iii) HOCH2CH2OMe, DDQ, 62%; (iv) t-BuLi, B(OMe)3, H2O2; (v) NaH, BnBr, 
CSA, 71%; (vi) TPAP, NMO, 91%; (vii) aq. HCl, 97%; (viii) MEMCl, i-Pr2NEt, 65%; 
(ix) Ag2O, BnBr, 65%; (x) TsOH, MeOH, 67%. 
 
1.4.6. Magnus and co-workers41,42 
 
Magnus et al. employed a β-azidonation to introduce the C4a stereocentre containing the 
nitrogen substituent into the silyl enol ether product 81.  The synthesis began with the 
methylenation and bromination of o-vanillin to yield to aryl bromide 78 in 65% yield 
(Scheme 12).  Lithiation of the aryl bromide, followed by the addition to ketone 79 gave 
the tertiary alcohol, which was then dehydrated to produce a double bond that was then 
hydrogenated, affording the desired ketone 80 in good yield.  The ketone was then 
protected in its enol form thus exposing the double bond nature of compound 81.  The 
double bond later underwent a shift with the addition of meta-chloroperoxybenzoic acid 
(m-CPBA), to give 82.  This compound was then reacted with EtOH/H3O+ to return the 
structure to its ketone form because the incorrect stereochemistry was obtained as C4.  
Various other attempts at elimination were carried out and finally a successful 
epoxidation from the α-face, to give 83 was confirmed.  By selective reduction of the 
ketone from the α-face followed by trans diaxial SN2 ring opening of the epoxide with 
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benzoate ion at C1, all the hydroxyl groups of the pancratistatin 4 ring C were 
stereoselectively installed.  Modified Bischler-Napieralski conditions were then used to 
induce the formation of the lactam, along with its regioisomer in a ratio of 1:7 in favour 
of the desired product.  The regioisomers were isolated in 60% yield, as an inseparable 
mixture.  Once deprotection occurred, the synthesis of pancratistatin 4 was completed in 
an overall yield of 1.2% over the 22 step synthesis. 
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Scheme 12.  (i) n-BuLi, THF, 85%; (ii) POCl3, DBU, pyridine, 97%; (iii) H2, Pd/C, 87%; 
(iv) Dioxane, H3O+, 89%; (v) B, LiCl, TIPSOTf, 95%, ≥85% ee; (vi) PhIO, TMSN3, 95%; 
(vii) LiAlH4, MeCOCl, pyridine, 56%; (viii) m-CPBA, 83%; (ix) EtOH/H3O+, 88%; (x) t-
BuOK, HMPA, 91%; (xi) TMSOTf, Et3N, PhSeOCOCF3, H2O2, pyridine, 64%; (xii) 
H2O2, NaHCO3, 75%; (xiii) L-selectride, 63%; (xiv) Ac2O, Et3N, 71%; (xv) PhCO2Na, 
Ac2O, pyridine, 60%; (xvi) Tf2O, DMAP, 60%; (xvii) BBr3, 70%; (xviii) NaOMe, MeOH, 
87%. 
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1.4.7. Rigby and co-workers43 
 
In 2000, Rigby and co-workers reported the syntheses of (+)-pancratistatin 4 and (+)-
narciclasine 2.  The key transformation in their syntheses ensued from the hydrogen bond 
controlled enamide photocylization, which in the case of pancratistatin 4, resulted in the 
desired trans-fused precursor 85 as seen in Scheme 13.   
 
The isocyanate 84 contained three of the necessary stereocentres at the start of the 
synthesis, although C1 had an inverted stereochemistry.  Irradiation of 85 gave 
phenanthridone 86.  The remaining hydroxyl groups were later introduced by conversion 
of the epoxide 86 into the olefin 87.  This compound could then be oxidized with osmium 
tetroxide to install the C3 and C4 hydroxyl groups at the β-face of ring C to finally reach 
the target molecule, pancratistatin 4.  The final product was achieved in an overall yield 
of 0.35% in 23 steps. 
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Scheme 13.  (i) –70°C, 52%; (ii) NaH, PMBBr, PPTS, 73%; (iii) hν, PhH, 30%; (iv) 
NaH, MeI, 98%; (v) TBAF, 85%; (vi) Dess-Martin, NaBH4, –20°C; (vii) NaH, BnBr, 
73%; (viii) (PhSe)2, NaBH4, H2O2, 84%; (ix) OsO4, 89%; (x) Pd(OH)2/H2, 87%; (xi) LiCl, 
DMF, 78%. 
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1.4.8. Kim and co-workers18,44 
 
Kim et al. utilized the Claisen rearrangement as a key step in their 2002 synthesis, by 
transforming the E-alkene 90, into the aldehyde 91 (Scheme 14).  Initially, a Horner-
Wadsworth-Emmons reaction was employed with the prepared phosphonate 88 and the 
aldehyde 89, in order to obtain the E-olefin 90 exclusively.  The C1 hydroxyl was then 
introduced by iodolactonization as shown by the intermediate 92.  Dihydroxylations and 
cyclic sulfate elimination reactions introduced the C2, C3 and C4 hydroxyl groups.  
Compound 93 was treated with osmium tetroxide (OsO4) on the α-face to produce a diol.  
The regioselective elimination of the C-3 hydroxyl group to generate the unsaturation 
was achieved by employing a cyclic sulfate elimination reaction; the cyclic sulfate was 
then treated with DBU in refluxing toluene to form the desired allylic alcohol 94.  The 
nitrogen was installed into the compound earlier in the reaction by the Curtius 
rearrangement with diphenylphophonic azide (DPPA), but lactamization was only 
accomplished by the Bischler-Napieralski cyclization to form the desired compound 95, 
along with a minor amount of regioisomer 96 in 78% combined yield and 7:1 
regioselectivity, later in the synthesis.   
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Scheme 14.  (i) LHMDS, 60%; (ii) PhMe, sealed tube, 78%; (iii) NaClO2, 
NaH2PO4.2H2O, 90%; (iv) KI3, DBU, 78%; (v) NaOMe, 93%; (vi) LiOH, 99%; (vii) 
DDPA, Et3N, NaOMe, 82%; (viii) BzCl, Et3N, 99%; (ix) OsO4, NMO, 96%; (x) SOCl2, 
Oxone, RuCl3.3H2O, 67%; (xi) DBU, H2O, THF, 67%; (xii) OsO4, NMO, 88%; (xiii) 
Ac2O, 77%; (xiv) Tf2O, DMAP, 78%; (xv) BBr3, 65%; (xvi) NaOMe, 83%. 
 
1.4.9. Li and co-workers20 
 
Li and co-workers have thus far been able to develop the shortest synthesis of (+)-
pancratistatin 4 in only 12 steps (Scheme 15).  The starting material used for the synthesis 
was pinitol 97, which is a somewhat expensive material because of its precise absolute 
stereochemistry.  It contains five of the necessary carbon stereocentres found in the 
cyclitol ring of the pancratistatin 4.   
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Scheme 15.  (i) i-Pr2SiCl2, imidazole, DMAP, 94%; (ii) (MeO)2C(CH3)2, p-TsOH, 81%; 
(iii) PPh3, DEAD, CH3SO3H, NaN3, 72%; (iv) TBAF, 100%; (v) SOCl2, Et3N, NaIO4, 
RuCl3, 87%; (vi) PPh3, H2O, 94%; (vii) MgBr2.OEt2, COCl2, 64% (viii) K2CO3, MOMCl, 
84%; (ix) t-BuLi, CeCl3, ultrasound, 72%; (x) BBr3, MeOH, 52%. 
 
The synthesis required the differential protection of the trans and cis hydroxyl groups 
with the bulky 1,1,3,3-tetraisopropyldisiloxane (TIPDS) group and an acetonide to 
provide product 98.  The configuration of the only remaining hydroxyl could then be 
inverted using the Mitsunobu reaction with methanesulfonic acid (CH2SO3H); this was 
followed by the insertion of the C4a nitrogen centre by azide substitution with a second 
inversion to get compound 99.  The Staudinger reduction then afforded the amine 100.  
The aryl substituent 101, which had been previously prepared, was reacted under the 
conditions shown in Scheme 15 to give the MOM protected amide 102.  The key 
transformation however, was the CeCl3-catalyzed intramolecular opening of the cyclic 
sulfate 102.  The organocerium, a softer nucleophile, was used as a halogen metal 
exchange, which led to nucleophilic ring opening of the cyclic sulfate closing the B ring 
of the pancratistatin precursor.  Thus the C10b centre was formed and the synthesis of 
pancratistatin 4 was completed in an overall yield of 9%. 
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1.5. Origins and background to the present project  
 
In the description of the main aim of the project, it will be necessary to discuss certain 
aspects pertaining to the project that may be of interest and could add some clarity to the 
topic. 
 
The Paulsen and Stubbe37,38 synthesis discussed previously (Section 1.4.3.) lends two 
very important synthetic protocols to our synthesis, the first being the use of D-(+)-
glucose 58 as a starting material, and the second is the use of conjugate addition as a key 
step for the introduction of the aryl substituent of pancratistatin. A detailed study of these 
aspects will be discussed in sections 1.5.1 and 1.5.2 below. 
 
1.5.1. Glucose and aspects of carbohydrates  
 
Carbohydrates have been extensively used as starting materials in enantioselective 
syntheses because they are a relatively inexpensive natural source of chiral compounds.45  
Glucose is normally represented in a chair conformation to best represent its five 
stereogenic centres.  Most carbohydrate building blocks are capable of existing in more 
than one form (pyranose and furanose forms), and glucose is no exception.  This is owing 
to the stereogenic centre closest to the oxygen in the tetrahydopyran ring (represented as 
an undefined hydroxyl group, whereas the other stereogenic centre consists of CH2OH), 
which exists as a hemiacetal and therefore the molecule is in equilibrium with the open-
chain aldehyde form (Figure 10).46  It is therefore important to control which forms 
glucose exists in, because of the added complexity pertaining to the glucose with its five 
stereogenic centres and the fact that it can exist as an open-chain system, and a 5-
membered or 6-membered ring systems.  The incorporation of protecting groups into the 
carbohydrate can therefore be pursued to ensure that only the hydroxyl groups required 
for certain reactions are available.47   
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Figure 10.  α- and β-glucose forms showing hemiacetal formation. 
 
Glucose has four chiral centres and exists in two groups of stereoisomers, L and D.  In 
addition to this when glucose cyclizes two anomers are formed owing to the asymmetric 
centre or anomeric carbon, C1.  These anomers differ structurally by the relative 
configurations of the position of the C1 hydroxyl group.  α-D-glucose contains a 
hydroxyl group in the axial position (or trans to C6, below the plane of the ring), while β-
D-glucose contains an hydroxyl group in the equatorial position (or cis to C6, above the 
plane of the ring).48 
 
1.5.2. Cuprate and rhodium catalysed conjugate addition 
 
The stereoselective insertion of the aryl substituent (ring A) of pancratistatin 4 onto the 
C10b site of the ring C fragment is an essential aspect to our synthesis of pancratistatin 4.  
The previous investigation into the synthesis by Paulsen and Stubbe37,38 showed that 
selectivity during the conjugate addition with the use of lithiated cuprates (i.e. compound 
65) was very poor and in fact an almost racemic mixture of diastereomers (compounds 66 
and 67) was achieved (Scheme 16).  Thus in our proposed synthesis, a further 
investigation into cuprate conjugate additions will be conducted, as well as some research 
into other possibilities for an approach to the selective addition of the aromatic moieties 
into the pancratistatin core. 
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Scheme 16.  (i)  CH2Cl2, 77% combined. 
 
In the case of our model synthesis and the proposed precursor required for many 
Amaryllidaceae compounds, including pancratistatin 4, the reaction of the aryl cuprate 
with the α,β-unsaturated compound should afford exclusively anti-selective product (for 
example compound 67, Scheme 16), although this is seldom the case.  There are many 
factors that have an effect on the outcome of the selectivity, such as the effect of 
solvents49 and additives,50 whether or not the cuprate being added is a higher or a lower 
order cuprate,50,51 and the electronic and steric properties of the alkene substrate.51  The 
investingation of these properties has continued intensively due to the mechanistic details 
of the cuprate reactions remaining elusive and under constant debate.  
 
The mechanism of the 1,4-conjugate addition reaction has been extensively studied both 
experimentally and theoretically.  There have been many proposed transition state models 
involving significant complexation between the metal centres and the substrate, which 
have accounted for the anti-selective additions.52  Early investigations proposed “CuIII 
intermediates” as the key transformation to the C–C bond by a reductive elimination of 
the β-carbon, where both square planar and T-shaped complexes have been proposed.53-55  
However, recent mechanistic investigations favour a “modified Felkin-Anh” 
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interpretation, in which an allylic 1,3-strain greatly destabilizes a transition state, owing 
to the acute angle of attack in the copper-π-complex, that leads to a syn-product.4  It has 
nonetheless been suggested that because of the complex and diverse nature of 
organocopper reagents, no single mechanistic model generally explains or predicts the 
outcome of these reactions.4 
 
It is for this reason, amongst others that will become apparent during the discussion of the 
synthesis, that an additional methodology was proposed to achieve the required 1,4-anti 
addition.  The Hayashi-Miyaura reaction of arylboronic acids under rhodium catalysis, 
had accomplished a high degree of versatility in that the reactions can be carried out with 
electron-deficient alkenes that are highly functional-group tolerant.56  Most importantly 
the reaction is water-tolerant, unlike the highly moisture-sensitive Grignard reactions, 
which are also conducted on a stoichiometric scale in terms of copper, whereas the 
rhodium compounds can be used sparingly in catalytic amounts.  The Rh-catalysed 
conjugate addition has also been shown to be highly anti-selective, irrespective of the 
double bond geometry.  This can be understood by transition state models in which steric 
destabilization is more energetically favourable thus leading to the formation of the 
desired anti product.  The nucleophile thus enters antiperiplanar to the lowest-lying σ* 
orbital γ-C-X groups (X = H, OR, CH2OR).56   
 
1.5.3. Aim and strategy of the project  
 
The aim of this project is to synthesize (+)-pancratistatin stereoselectively, using D-(+)-
glucose, and by using a similar strategy employed by Paulsen and Stubbe in 1983 who 
utilized a nitroalkene and inserted the aryl substituent by conjugate addition (see Scheme 
17).37,38  An additional adaption to the above project will attempt the formation and hence 
the use of an enoate in the place of the nitro group, which will undergo a similar 1,4-
addition for the introduction of the aryl group.  Finally, a variety of aromatic anologues 
will be produced to create a library of compounds that could be potentially analyzed for 
biological activity against a variety of cell lines as well as to compare the biological 
activity with pancratistatin 4. 
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Scheme 17 details the proposed steps for the formation of the nitroalkene 105 and the 
enoate 106, which are known building blocks in carbohydrate chemistry and have been 
used considerably in natural product synthesis.  The commercially available sugar is 
trapped into its furanose form under acetalisation conditions (step i), the remaining 
hydroxyl can then be protected as a benzyl ether 103 (step ii), which can then undergo 
selective deprotection of one acetonide (step iii), followed by an oxidation to produce the 
aldehyde 104 (step iv).  The synthesis would diverge at this point into the nitroalkene 
105, prepared by a Henry reaction (step v), and into the enoate 106 prepared by a Horner-
Wadsworth-Emmons reaction (step vi). 
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Scheme 17.  Proposed synthetic route for the preparation of α,β-unsaturated compounds. 
 
Scheme 18 and 19 show the possible approaches to the formation of the ring C and finally 
the ring B of pancratistatin 4.  The routes would progress in a similar fashion, with the 
described conjugate addition (Section 1.5.2) occurring, followed by the deprotection of 
the acetonide (step iii) to expose the hemiacetal in the furanose sugar moiety.  We 
envisage that if the carbon α to the nitro group in 107 is treated with a mild base as 
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previously seen in the Paulsen and Stubbe synthesis,37,38 that this will induce ring closure 
and thus set into place the C ring of pancratistatin with all its stereogenic centres intact 
and the functionality necessary to create the lactam and thus final ring A.   
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Scheme 18.  Proposed synthetic route for pancratistatin and its analogues from 
nitroalkene 105. 
 
The nitrogen is already in place in Scheme 18 and thus once ring closure has occurred all 
that is expected is for nitro 108 to be reduced into the amine 109.  This compound should 
then be transformed into an isocyanate and undergo the Bischler-Napieralski reaction 
(step v) to form the natural product 4.  Similarly, in Scheme 19, once ring C has formed, 
the amide 111 can be produced from a Curtius-type reaction (step iv) on the ester 
functionality 110 (via a conversion to the carboxylic acid), which can then undergo the 
Bischler-Napieralski reaction as in Scheme 17 to produce pancratistatin 4.  The same 
methodology can then be employed to prepare analogues with varying aromatic 
substituents. 
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Scheme 19.  Proposed synthetic route toward the synthesis of pancratistatin and its 
analogues with enoate 106. 
 
Chapter 2                                             Results and Discussion – Enoate and nitroalkene 
 
CHAPTER 2:  RESULTS AND DISCUSSION  
THE SYNTHESIS OF THE KEY ENOATE AND NITROALKENE 
 
2.1. Toward the aldehyde precursor 104 
 
The methodology for the formation of the sugar derivatives shown in Scheme 20 has been 
well documented and several isomers are commercially available.  D-(+)-Glucose 58 was 
used as the starting material for the synthesis because of its commercial availability and 
in view of the fact that it contained the stereochemical information required for the 
synthesis of the cyclitol C ring of pancratistatin 4.  The envisaged synthetic route for this 
section of the project are shown in Scheme 20. 
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Scheme 20. Retrosynthetic route to aldehyde precursor 104. 
 
This specific form of D-(+)-glucose 58 was chosen as the chiral material necessary to 
produce the sought after product.  Optical rotation of the material gave an indication of 
the purity of the material.  The reported literature value of the α-D-glucose anomer was 
[α]D = +109.0 (c 4.0, H2O, 20 °C)57 and the value attained from our optical analysis 
showed that the specific rotation was +91.3 (c 2.0, H2O, 22 °C), therefore confirming that 
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our purchased glucose was the correct anomer.  The specific rotation of the β-D-glucose 
anomer is reported as +20.1 (c 2.0, H2O, 25 °C).57 
 
2.1.1. Synthesis of the 5-membered furanose 112 
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Scheme 21.  (i) CH3COCH3, I2, r.t., 20 h, 58%. 
 
D-(+)-Glucose 58 was treated with acetone in the presence of iodine to form the protected 
furanose diacetonide derivative of glucose 112 (Scheme 21).47  The reaction was found to 
be highly selective for the formation of the 5- rather than the 6-membered ring, because 
the 6-membered pyranose ring has been shown to adopt a stable chair conformation more 
readily on reacting with acetone.  In this case, the more likely arrangement of the newly 
formed compound would distinguish one of the methyl groups of the acetone as axial and 
there would therefore be a direct interaction between the methyl group and the axial 
hydrogen, which would be sterically and energetically unfavourable.  Conversely, the 
furanose form has a larger probability of undergoing the protection due to the proximity 
of the 1,2-diols in the structure, which will thus demonstrate a greater selectivity toward 
the acetal fusion, which the pyranose glucose does not adhere to because of its complex 
conformational structure.46,57 
 
In the 1H NMR spectrum of bisacetal 112 four prominent methyl 
singlet peaks at 1.50, 1.45, 1.37, and 1.32 ppm were the foremost 
features observed.  This gave a clear indication that the glucose 
had been protected as the acetonide at both of the required sites 
on the starting material.  When comparing the spectrum to that of glucose, it became clear 
that the material had undergone the transformation from the 6-membered to the 5-
O
O
O
O
O
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3a
6a
6
5
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membered ring, based on the complex hydrogen couplings.  The doublet furthest 
downfield (δ = 5.94 ppm) was assigned to the H-3a with J = 3.6 Hz.  The 3a-H hydrogen 
could be regarded as acetal hydrogen due to the acetonide protection and for this reason 
and because of the close proximity of the polar oxygen groups, the signal was observed 
remarkably downfield.  A CH correlated spectrum (HSQC) was used to assign all the 
carbon signals to their respective hydrogen signals and to clarify some of the complexity 
in the spectrum.  For instance, the CH2 protons could be easily deduced from the 
spectrum, as they showed nonequivalence.  Each of the corresponding 1H NMR signals 
separated into doublet of doublet signals at 4.17 and 4.00 ppm.  The H-4’ signal was 
complex due to the overlap with the H-6 signal.  It would be expected that the H-4’ 
proton would split into a doublet of doublet of doublets due to the two nonequivalent 
CH2’s and H-5.  Coupling appeared to have occurred between the OH proton and the 
proton of H-6 as evident from the doublet at 2.76 ppm.  No coupling between H-6 and H-
6a was apparent with H-6a producing only a doublet due to coupling H-3a.  The possible 
outcome of the H-6 signal could then be understood to be a doublet of doublets.  The IR 
spectrum of the acetonide protected compound 112 clearly showed the appearance of the 
acetonide CH3 peaks in the 2984 and 1458 cm-1 region. 
 
2.1.2. Benzylation of the remaining hydroxyl to synthesize 10358,59 
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Scheme 22.  (i) NaH (65% in oil), Bu4NI, BnBr, THF, r.t., 22 h, 72%. 
 
The protection of the remaining unprotected hydroxyl group was carried out with benzyl 
bromide and a base (Scheme 22).  This was necessary for the subsequent acetonide 
deprotection to occur successfully and because of the benzyl group’s stability toward 
most organic and inorganic reagents (requires hydrogenation over Pd/C for deprotection).  
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Furthermore, it was necessary for the remaining hydroxyl to be protected, owing to the 
nucleophilicty of the oxygen posing a potential problem as well as the potential for the 
polar hydroxyl to generate a more insoluble compound (insoluble in organic solvents).  
The salt tetrabutylammonium iodide (Bu4NI) was used as a phase transfer catalyst to 
ensure optimal results during the benzylation process (Scheme 22). 
 
The most notable feature in the 1H NMR spectrum of compound 
103 was the appearance of the aromatic multiplet in the region of 
7.36-7.30 ppm, which integrated for exactly five protons.  
Another obvious feature was the disappearance of the OH signal 
at 2.76 ppm.  This together with the benzyl ether caused the H-6 
proton signal to be unambiguously assigned which was not 
observed previously with compound 112.  Accordingly, H-3a and H-6a were observed to 
couple only to each other and H-6a did not couple to H-6.  This was probably due to the 
dihedral angle between and H-6a being approximately 90°, causing coupling to be very 
weak.  The CH2 from the benzyl could also be accounted for, although the H-1a” and H-
1b” protons were observed as nonequivalent and the signals were embedded in the H-5’ 
and H-5 signals, making full interpretation of coupling problematic.  In the 13C NMR 
spectrum, the aromatic region unmistakably accounted for the benzyl group at 129.5, 
129.0 and 128.6 ppm.  Lastly, the IR spectrum clearly showed the loss of the OH peak in 
the region of 3424 cm-1.  An [α]D was obtained for the benzylated product 103 of –22.5, 
which was found to be in good agreement to the reported literature value of –21.6.58 
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2.1.3. Selective isopropylidene deprotection to synthesize 1,2-diol 113 
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Scheme 23.  (i) 50% acetic acid/H2O, r.t., 48 h, 76% or conc. HCl, MeOH, r.t., 96 h, 
78%. 
 
Selective deprotection transpires quite readily on acetonide groups that are not fused to 
the 5-membered ring.  This occurs not only because of the increased steric hindrance of 
the ring system but also because of the ether oxygen adjacent to the C-5’ methylene 
group, which will react readily under the mildly acidic conditions, leaving the remaining 
isopropylidene unaffected.  The selective deprotection of the acetonide was initiated 
using a 50% aqueous mixture of acetic acid and the reaction was allowed to take place 
over several days (Scheme 23).60  A TLC analysis showed that the reaction had failed to 
go to completion; however, despite this the yields were reasonably high at 76%.  Another 
method59,61 was later utilized which used a solution of water, methanol and concentrated 
hydrochloric acid to promote the deprotection (Scheme 23).  The TLC analysis of this 
method also showed that the reaction did not fully go to completion.  Nonetheless, 
product 113, a highly viscous yellow oil was obtained in 78% yield. 
 
The upfield region of the 1H NMR spectrum clearly showed the loss of two CH3 singlets.  
Interestingly, the OH protons all coupled to the adjacent protons on the carbon, thus 
making the central region of the spectrum highly complex.  For instance, the OH signal 
adjacent to the H-5’ CH2 gave a triplet signal, whereas the OH adjacent to H-4’ gave a 
doublet.  Similarly, the H-5’ and H-4’ signals became more complicated due to their 
added coupling to OH over and above their other couplings.  Thus in the NMR spectrum 
these signals appeared as broad multiplets, however, in actuality the nonequivalent H-5’ 
protons should appear as a doublets of doublets of doublets and the H-4’ proton should be 
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a doublet of doublet of doublet of doublets (dddd).  The spectrum did however clearly 
show the benzyl CH2’s H-1a” and H-1b”, the nonequivalent protons were observed at 
4.71 and 4.56 ppm on the spectrum and each signal split into a doublet, which gave 
geminal coupling of 11.8 Hz.  As seen previously with IR spectroscopic analysis, the OH 
signal reappeared in the region of 3423 cm-1 as expected. 
 
2.1.4. Synthesis of aldehyde 10459,61 
 
113 104
O
O
O
HO
HO
BnO
O
O
O
O
BnO
H
(i)
 
 
Scheme 24  (i) NaIO4, MeOH, H2O, 0 °C–r.t., 96% crude yield. 
 
Under the influence of an aqueous solution of sodium periodate (NaIO4), at low 
temperatures, the exposed diol 113 was readily cleaved into the aldehyde 104 as depicted 
in Scheme 24.  The reaction formed a white emulsion which after an aqueous work-up 
afforded the desired product 104 as a clear colourless oil. 
 
The TLC of this reaction mixture showed a distinct difference in Rf (0.41 to 0.75) 
indicating the formation of a less polar entity, with no indication that any starting material 
remained.  Figure 11 illustrates the possible mechanism for the formation of the aldehyde 
with the oxidant NaIO4.  The aldehyde 104 was assumed to be unstable and therefore as a 
precaution was not purified further but carried directly through to the next reaction step 
(Section 2.2 & 2.3).   
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Figure 11.  Proposed mechanism for the cleavage of diols by sodium periodate.57 
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The 1H NMR and IR spectra for the crude aldehyde 104 both indicated the presence of 
the aldehyde through a distinct aldehyde peak.  An aldehyde proton singlet was observed 
at 9.67 ppm in the 1H NMR spectrum and significant peaks at 2936 cm-1 (C-H stretch) 
and 1738 cm-1(C=O stretch), as well as the loss of the broad OH peak, undoubtedly 
signified the presence of the aldehyde in the IR spectrum. 
 
2.2. Horner-Wadsworth-Emmons reaction to synthesize compound 106 
 
Having prepared the aldehyde 104, a carbonyl extention reaction was required, namely 
the Horner-Wadsworth-Emmons reaction.  It was anticipated that the reaction would 
produce the required E-alkenoate ester.  Stereoselectivity in Wittig reactions depends on 
the nature of the substituent on the carbon of the ylid.  Stabilized ylids contain anion-
stabilizing substituents or are in conjugation with adjacent substituents and therefore are 
able to balance the charge from the phosphorus cation.  E-selectivity is therefore more 
likely to occur in the Horner-Wadsworth-Emmons reaction because of the reaction with 
phosphonate esters and their ability to form good stabilized ylids.  The preference toward 
E-selectivity of the stabilized ylids is thought to be due to thermodynamic control taking 
preference over kinetic control, and therefore the intermediate oxaphosphetane formation 
being more stable in the anti arrangement, resulting in the major product being the E-
alkene.46 
 
The phosphonate ester, trimethyl phosphonoacetate, was thus treated with NaH (60% in 
paraffin oil) in THF at –60 °C.  The reaction mixture was then left to warm to room 
temperature so that deprotonation could occur.  The reaction vessel was again cooled to  
–60 °C and the aldehyde 104 was added to the reaction mixture (Scheme 25).  The 
reaction was then left to stir for 20 hours.  The total consumption of starting material was 
observed by TLC.  However, purification needed to be performed by flash column 
chromatography for ideal separation and good purity.  Nevertheless, the procedure proved 
to be quite successful and afforded the desired E-alkene 106, in a yield of 78% based on 
diol 113. 
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Scheme 25.  (i) Trimethyl phosphonoacetate, NaH (60%), THF, 78% – trans-106, 
          2% – cis-106. 
 
In the 1H NMR spectrum, the loss of the aldehyde peak at 9.67 
ppm suggested that the reaction had been successful.  The 
appearance of a new singlet at 3.66 ppm indicated that the 
methyl protons H-1’ were present and that the methyl 
propenoate had indeed formed.  Protons H-2’ and H-3’ were significantly deshielded due 
to the presence of the alkene system conjugated to the carbonyl ester.  The two doublet of 
doublet signals of H-2’ and H-3’ gave the vicinal coupling constants of 15.8 Hz, 
maintaining that the E-isomer (trans-106) was in fact the major isomer isolated.  On 
occasion, very small quantities of the Z-isomer (cis-106) could be isolated (1:25 ratio 
compared to E-alkene).  The 3J coupling for the minor Z-isomer was found to be 11.7 Hz.   
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Several other interactions of interest giving some insight into the arrangement of the 
compound were ascertained from the NOESY spectrum.  For instance, the interaction of 
H-3a and H-6a with only one methyl group from the adjacent acetonide protecting group 
gave a clear indication as to how the methyl groups are arranged.  The remaining methyl 
group on the acetonide was seen to interact only with the H-5 proton, thus indicating that 
the proton was on the opposite face to H-3a and H-6a, as expected.   
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2.3. Henry reaction to synthesize the nitroalkene 105 
 
The formation of a second alkene compound 105, containing a nitro functionality instead 
of the ester observed above (Section 2.2), was attempted through the application of the 
Henry reaction.  The already prepared aldehyde 104 was utilized for the preparation of 
the nitroalkene 105.  The Henry reaction or nitroaldol reaction occurs between an 
aldehyde 104 and nitromethane.  Nitromethane has a pKa of 10.2 and therefore 
deprotonation at the position adjacent to the nitro group may be achieved with a number 
of mild bases.  The nucleophilic addition will therefore occur readily with the aldehyde, 
followed by an elimination to attain the nitroalkene 105 (Scheme 26).46,62,63 
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Scheme 26.  (i) CH3NO2, Et3N, Et2O, 95% mixture of diasterioisomers (7:1 ratio);  
         (ii) MeSO2Cl, Et3N, Et2O, 84%. 
 
 
 
 
2.3.1. Preparation of epimeric nitroalcohols 114a and 114b62,64-66 
 
The nitroalcohols were prepared by a reaction of the previously prepared aldehyde 104 
with nitromethane (Scheme 26).  The base used to deprotonate the nitromethane and 
induce the aldol-type reaction was triethylamine (Et3N).  The reaction mixture was 
purified by column chromatography by increasing the polarity from 5 to 20% 
AcOEt/hexane.  The major isomer 114a, which existed in the α-D-gluco-configuration 
and the minor isomer 114b, in the β-L-ido-configuration were isolated in a 7:1 ratio.  The 
establishment of the relative configuration will be explained below.  
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The 1H NMR spectral analysis was very similar for both 
isomers.  There was no evidence for the presence of the 
aldehyde 104 and hydroxyl peaks could be clearly distinguished.  
Only very subtle shifts in the spectrum were indicative of the 
difference in the spectra of the isomers.  The β-L-ido-
nitroalcohol was observed to have a slight downfield shift in the 
distinctive 3a-H doublet at 6.00 ppm, the shift of the OH peak was also slightly affected 
to 3.34 ppm.  The major α-D-gluco-epimer contained an additional spectral feature, in 
that the signal for the OH was not a broad singlet as seen with its isomeric counterpart; 
instead, it was found to couple to generate a doublet.  It was suspected that the OH may 
have coupled with the H-1’ proton adjacent to the hydroxyl group, however as a result of 
overlapping peaks and the H-1’ signal appearing as a broad multiplet, closer inspection of 
the COSY spectrum indicated that no coupling occurred.  Intramolecular hydrogen 
bonding between either the benzyl ether oxygen or the nitro oxygens and the hydrogen of 
the hydroxyl on C-1’was possible when considering the distortion of the compound based 
on ring strain.  Nonetheless, the most plausible reasoning was that intermolecular 
hydrogen bonding could have occurred with water that was present in the sample.  In 
addition, a NOESY spectrum of the product suggested interactions with water.  It was 
therefore necessary to add D2O to a sample of the major α-D-gluco-epimer 114a to 
analyze the change in coupling relative to the hydroxyl to the doublet at 2.64 ppm.  The 
loss of the hydroxyl doublets showed no effect on the remaining spectrum and thus led to 
the conclusion that the compound was indeed interacting with water.  The configuration 
of the isomers 114a/b was assigned based on a comparisons made from c
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The IR spectra of the isomers 114a/b gave a clear indication that the reaction had 
proceeded, due to the disappearance of the peaks coinciding with an aldehyde in the 
region of 1720 cm-1 and the appearance of the distinctive alcohol peaks (OH stretch) at 
3448 cm-1. The presence of the NO2 was also observed by a significant peak at 1550 cm-1.  
The specific rotation for the major isomer 114a was [α]D = –37, which was in satisfactory 
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agreement to the literature value of  –4067.  The optical rotation of the minor isomer 114b 
confirmed that the isomer was actually an epimeric mixture since the [α]25D64 = –107 in 
the literature coincided with the obtained value of –110.5.  This was also corroborated by 
the fact that the isomer did not form a white solid as expected.  It could not be purified 
rther; however, the results were substantial on the basis of comparison. 
 
.3.2. Dehydration to synthesize nitroalkene 105 
 dehydration occurred without any major differences 
 the outcomes, as expected.64,65,68 
more complex due to coupling with both of the alkene hydrogens as well as H-6, thus 
fu
2
 
The dehydration in Scheme 26 was performed with both the pure α-D-gluco-epimer and 
with the mixture of both epimers.  Methanesulfonyl chloride (MeSO2Cl) was slowly 
added to the reaction mixture containing the pure nitroalcohol 114a in diethyl ether 
(Et2O) and triethylamine (Et3N); on addition of the MeSO2Cl a haze of gas was emitted 
and a yellow glutinous substance precipitated in the flask.  The mixture was then left to 
stir overnight, after which it was neutralized with acid, extracted and purified (column 
chromatography) to afford nitroalkene 105 as a yellow oil.  When comparing the outcome 
of the product to when the mixture of epimers was used and when the starting compound 
contained only the major isomer, the
in
 
O
 In the 1H NMR spectrum of compound 105, intricate coupling 
occurred due to the formation of the alkene, which made for an 
almost completely transformed spectrum (in regard to the central 
region of the spectrum when compared to its nitroalcohol adducts 114).  Proton H-3a was 
unchanged and only coupled to H-6a to give a doublet.  Proton H-6a was embedded 
within the CH2 signal of the benzyl region at 4.67 ppm.  The 13C NMR spectroscopy 
signals for C-6a and C-6 were closely related to one another giving values of 82.4 and 
82.3 ppm, respectively.  In addition, the nonequivalent protons in the benzyl CH2 gave 
two expected doublets at 4.66 and 4.56 ppm with a coupling constant of approximately 
12.0 Hz.  Finally, the presence of the alkene led to the H-5 proton becoming considerably 
O
O
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becoming a doublet of doublet of doublets, although it appeared as a doublet of triplets on 
the spectrum due to similarities in two of the three coupling constants. 
  
The nitro group is electron-deficient; therefore the electron density in the alkene is 
expected to be distorted toward the nitro site.  The β-proton would thus be expected to be 
deshielded as confirmed by the chemical shift at about 7.31 ppm which is rather 
downfield due to these interactions.46  It was therefore expected for our alkene protons to 
be as far downfield as our aromatic protons at 7.39–7.20 ppm.  It was also thought that 
both alkene signals would produce a doublet of doublets due to their interaction with each 
other and H-6, nonetheless, only one doublet of doublet signal could be clearly observed 
and analysed within the aromatic region at 7.16 ppm, with coupling constants of 13.3 and 
3.5 Hz.   
 
In the next chapter, the prepared unsaturated alkenes 105 and 106 will be used in an array 
of conjugate addition reactions, in an attempt to insert the aromatic A ring into the 
pancratistatin precursor.  The conjugate addition procedures and the aromatic derivatives 
used will be described accordingly. 
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CHAPTER 3:  RESULTS AND DISCUSSION 
CONJUGATE ADDITION 
 
In this chapter, the stereoselective addition of aromatic derivatives by conjugate addition 
to the systems described in the previous chapter will be discussed.  The chapter will begin 
by describing in Section 3.1 and 3.2 the most appropriate method for achieving this 
stereoselectivity, so as to attain the necessary pancratistatin precursor.  The result 
obtained in this project will then be described. 
3.1. The use of cuprates in conjugate addition: The work of Paulsen and 
Stubbe37,38 
 
Initially, the organocuprate method for conjugate addition was adapted to insert the 
aromatic ring substituent into our developing synthetic system (described previously in 
Chapter 2) with the expectation of achieving the stereoselectivity necessary to eventually 
introduce the troublesome trans fused ring system, one of the major synthetic challenges 
in making pancratistatin 4 (Scheme 27).  A modified Felkin-Anh model was proposed 
suggesting that the nucleophilic organocuprate would react on the opposite face to the 
alkoxy group as seen in Scheme 27.69   
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Scheme 27:  Proposed anti configuration based on the modified Felkin-Anh model. 
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In a previous attempt to perform the conjugate addition, Paulsen and Stubbe37,38 
employed lithiated cuprates in an effort to achieve the synthesis of sufficient L-allo-
product 63 (Scheme 28), unfortunately, with only modest success.  After a comprehensive 
literature survey30,67,69-71 was carried out, an adaption to the methodology was initiated 
with stereoselectivity in mind.  This will be presented in detail in Section 3.3.1. 
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Scheme 28.  Previous conjugate addition by Paulsen and Stubbe.37,38 
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3.2. Conjugate addition with arylboronic acids under rhodium(I) catalysis 
 
A brief survey of the literature, led to a paper by Segura and Csaky,56 in which the 
Hayashi-Miyaura reaction72 was applied to conjugate esters.  They showed that a 
tereoselective synthesis could be achieved through the application of rhodium 
dynamically stable oxa-π-allylrhodium B.  This complex then forms the 
ydroxorhodium complex C on addition of water, thus liberating the final arylated 
product.   
 
s
complexes, and they proposed a mechanism for the transformation.   
 
The Hayashi-Miyaura reaction involves the reaction of unsaturated esters with 
organoboronic acids using cyclooctadiene rhodium chloride dimer {[(cod)RhCl]2} as the 
catalyst, in a dioxane-water (10:1) solution in the presence of a base.  It has recently been 
proposed that the catalytic cycle of the rhodium conjugate addition mechanism, 
illustrated in Scheme 29, contributes greatly to the understanding of the 
diastereoselectivity of the newly formed carbon-carbon adducts.73  The cycle proceeds 
with three intermediates, the first being the arylrhodium A which binds to the alkene 
making it more electrophilic.  Alkene coordination is followed by diastereoselective 
insertion of the alkene into the rhodium-carbon bond followed by isomerisation to form 
the thermo
h
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Scheme 29.  Proposed catalytic cycle for rhodium(I) catalysts 
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The mildness of the reaction conditions circumvents aldol condensations of the substrates 
and products which could be problematic in a basic environment.  However, under these 
conditions, hydrolytic deboronation of the arylboronic acid can be a competing side 
reaction, which can be overcome by adding an excess of boronic acid.  Moreover, in 
nearly all of the rhodium-catalyzed conjugate addition reactions a side reaction occurs 
due to catalytic demetalation of the organometallic component.  This occurs because the 
aryl-rhodium bond is more sensitive to protonolysis than the original organometallic 
compound from which it was derived.   
 
The stereochemical outcomes of the conjugate addition reactions have been rationalized  
by Segura and Csaky through transition state models that minimize steric interactions.  A 
nonchelation-controlled model was thus used to better understand the means by which the 
compound would undergo conjugate addition in a stereoselective manner.56  It has been 
suggested that the formation of the oxo-π-allyl-Rh1 intermediate B (Scheme 29) could 
possibly be the rate-limiting step in the catalytic cycle and thus the assumption could be 
made that diastereoselection could take place at this point.   
 
In Figure 12, two possible models are proposed, which describe the stereochemical 
outcome of the conjugate addition reactions.  Model I (Figure 12) predominates as it 
leads to the desired anti adducts.  The syn adducts of model II are destabilized by steric 
congestion between the phenyl and benzyloxy substituents; as indicated. 
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Figure 12.  Proposed stereochemical outcome for aromatic additions. 
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The numerous attempts at conjugate addition using a variety of aromatic adducts will be 
describe below in Section 3.3, in relation to the previously prepared α,β-unsaturated ester 
106 and in Section 3.4, in relation to the nitroalkene 105.  
 
3.3. Conjugate addition of aryl groups to α,β-unsaturated esters  
 
3.3.1. Conjugate addition of phenyl group to ester 106  
 
As part of the initial model investigation of the synthesis of pancratistatin, it was 
advantageous to attempt the conjugate addition using a simple, more cost-efficient aryl 
system for insertion into the enoate adduct 106, for both synthetic and economical 
purposes.   
 
The cuprate reagent for our proposed synthesis was prepared from a transmetallation 
reaction with the corresponding aryl Grignard.  Therefore, it was necessary to first 
synthesize the Grignard reagent under dry conditions due to its hygroscopic nature.  The 
Grignard reagent was thus prepared using magnesium turnings which underwent an 
exothermic reaction with bromobenzene in THF.  The Grignard reagent was then 
transferred by cannula into a cooled suspension of cuprous iodide (CuI) in THF.  During 
the reaction the suspension changed in appearance from an opaque white to a dark yellow 
colour.  The alkene 106 was then dissolved in THF along with the trimethylsilyl chloride 
(TMSCl) which was also cannulated into the organocuprate reagent. 
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Scheme 30.  (i) PhBr, Mg, CuI, Me3SiCl, THF, –78 °C–r.t., 55% or  
                      PhB(OH)2, [(cod)RhCl]2, Et3N, dioxane/water (10:1), r.t., 94%. 
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Purification of the product was fortunately possible, despite the TLC (10 and 20% ethyl 
acetate in hexane) depicting a range of spots.  With the use of column chromatography 
(10% ethyl acetate in hexane) the highest yield achieved for the conjugate addition to 
afford compound 115 was 55% (Scheme 30).  However on average yields of only 40% 
were isolated for both the nitro and ester adducts when bromobenzene was added.  This 
yield was improved slightly with the nitro adduct as it was found that the use of TMSCl 
was not important and could be omitted (see Section 3.4). 
 
In an attempt to investigate the problems relating to the moderately low yields the 
Grignard reagent was added in an excess of 20 equivalents, relative to the starting 
material 106, in an attempt to increase the yield of the final product 115, as it was 
suspected that the preparation and transfer of the Grignard reagent at an earlier stage of 
the reaction was causing the low yields.  It was established that the complication in the 
preparation of the Grignard reagent was due to the reaction not going to completion, even 
if the reaction mixture was heated.  This was thought to arise from the grade and surface 
exposure of the magnesium turnings and the possible rapid degradation of the Grignard 
reagent itself. 
 
The rhodium method for conjugate addition of phenylboronic acid to enoate 106 was far 
more efficient; the reaction was persistently higher yielding and afforded almost 
exclusively the (3’S)-diastereomer.  Initially, a mixture of diastereomers was achieved 
once purification by standard silica gel column chromatography was performed; however, 
later it was discovered that the diastereomers (115-3’S and 115-3’R) could be separated 
using flash chromatography.  Consistently, the ratio of diastereomers was found to be 
approximately 12:1. 
 
The 1H NMR spectrum of the isolated major diastereomer 
115, was especially encouraging with numerous interesting 
novel couplings as well as some anticipated peaks.  As 
expected, the alkene peaks previously reported with chemical 
shifts in the region of 6.40-5.65 ppm, had disappeared.  From 
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the C-H correlated spectrum (HSQC) both CH2 groups could be assigned.  It was 
previously observed that the benzylic protons showed nonequivalence, and this was also 
expected with the protons at C-2’ because of the formation of the new chiral centre 
adjacent to it.  The two C-2’ protons gave rise to the peaks most upfield at 3.89 and 3.68 
ppm, both giving doublets of doublets, with the geminal coupling of 15.6 Hz.  
Furthermore, the positions of the individual hydrogens in the structure could be estimated 
from the coupling interactions between the hydrogens.  A 3J value of 10.5 Hz was 
observed for H-2’–H-3’which suggested a dihedral angle of approximately 180°, based 
on the Karplus equation.74  This projection led to the deduction that the added phenyl 
adduct had stereochemistry that was overall anti (C-3’ and C-5) because of the position 
of H-5 in relation to H-3’.  The stereochemistry at C-5 was already known and therefore 
the stereochemistry of H-3’ could be confirmed.  It could also be assumed by analogy, 
based on the X-ray crystal structure of 117 (Section 3.4) that the similarities in the 
aromatic groups would lead to similar overall (3’S)-stereochemical arrangement for 
compound 115. 
  
The H-3a signal was generally used as a “reference point” for the analysis of most of the 
compounds prepared, because of the signal’s distinguishable position in the spectrum.  
For instance, in the 1H NMR spectrum of the minor diastereomer a slight upfield shift in 
the peaks of the doublet in the region of 5.95-6.00 ppm could be seen, corresponding to 
the H-3a proton.  Accordingly, when analyzing the spectrum of the diastereomer for the 
conjugate addition product various other shifts were also discerned, especially where 
signals of H-2’ and H-3’ were concerned.   
 
At this point a debenzylation was attempted under hydrogenation conditions using 10% 
palladium on carbon in methanol at a pressure of 7 bar, the reaction was left at room 
temperature for 72 hours.  It was expected that lactone formation would occur with the 
exposed hydroxyl and the ester (Figure 13).  It was assumed a lactone would more 
readily form a solid and thus potentially crystals.  From the crystal a more accurate 
depiction of the stereochemistry could be obtained by the use of X-ray diffraction 
analysis.  The rigidity of the lactone would hopefully also improve NMR analysis and 
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allow stereochemical assignments by the use of coupling constants.  However the 
debenzylation did not occur, most probably as a result of the conditions being too mild 
and therefore the reaction was abandoned. 
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Figure 13.  Attempted debenzylation and lactonization of ester 115. 
 
3.3.2. Synthesis of conjugate addition compound 116 
 
Conjugate addition using cuprate methodology was not attempted using the 
dioxolylphenyl substrates because the rhodium-catalyzed approach was found to have 
improved results.  The addition of commercially available 3,4-dioxolylphenylboronic 
acid to the enoate adduct 106 (Scheme 31) proceeded by a procedure equivalent to that 
described previously (Section 3.2).  However, the reaction required longer reaction times 
and only produced the major product in a yield of 26%, with the diastereomers produced 
in a 7:1 ratio.  The reaction conditions were not optimized due to the abandonment of the 
ester approach of the project (See Chapter 4 for discussion). 
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Scheme 31.  (i) 3,4-(OCH2O)C6H3B(OH)2, [(cod)RhCl]2, Et3N, dioxane/water (10:1), r.t., 
           26% 
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When comparing the 1H NMR spectrum of the newly formed aryl addition product 116 to 
the phenyl compound 115, a prominent difference was the aromatic region which showed 
three distinct multiplets at 7.38-7.24 ppm (five benzyl protons), 6.74-6.67 ppm (three 
dioxolyl protons), and 5.98-5.87 ppm (dioxolyl CH2 and H-3a signal).  The central region 
of the spectrum was in agreement with that observed for the spectra of adduct 115.  
Analysis of 116 by high resolution mass spectrometry afforded a mass of 456.1762 amu, 
in good agreement with the expected value of 456.1784 amu.  The stereochemistry for the 
addition was assumed based on the same arguments postulated in the previous system 
described in Section 3.3.1.. 
 
3.4. Conjugate addition to nitroalkenes 
 
Investigation of conjugate addition using both the organocuprate and the rhodium-
catalyzed method on the nitro olefin was an important component of this research in 
order to replicate the Paulsen and Stubbe-type37,38 chemistry established in 1982.  
However, it was anticipated that the novelty in the conjugate addition methodology 
would lead to an improved stereochemical ratio as compared to that achieved by Paulsen 
and Stubbe reported previously. 
 
It was decided that a variety of aromatic adducts would be investigated (Table 3.1), in 
order to better understand the underlying principles of conjugate addition with our system 
and for the investigation of the synthesis of potential pancratistatin analogue precursors.  
The aromatic substituents were chosen because of their oxygen donating groups, which 
could possibly mimic the biological and medicinal potential of analogues of pancratistatin 
4.  All of the arylboronic acids used were commercially available and used as supplied. 
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Scheme 32.  (i) PhBr, Mg, CuI, Me3SiCl, THF, –78°C–r.t., 55% or  
                      ArB(OH)2, [(cod)RhCl]2, Et3N, dioxane/water (10:1), r.t., 30–84%. 
 
 
Table 3.1.  Aromatic groups and yields for conjugate addition reaction. 
 
Compound Ar Scale (mmol) [α]22D Yield (%) 
 
117 
 
 
 
6.10 
 
-28.6 
 
(55)* 68 
de = (6:1)*14:1 
 
118 
 
O
O  
 
6.75 
 
-37.0 
 
84 
 
 
119 
 
O
O  
 
1.15 
 
-36.5 
 
48 
 
 
120 
 
MeO
MeO
OMe  
 
 
1.12 
 
-36.2 
 
38 
*Yield and diastereomeric excess (de) corresponds to the cuprate conjugate addition experiment. 
# Diastereomeric excess for 118, 119 and 120 were not attainable. 
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Initially (3aR,5R,6R,6aR)-2,2-dimethyl-5-[(1R)-2-nitro-1-phenylethyl]-6-[(phenylmethyl) 
oxy]tetrahydrofuro[2,3-d][1,3]dioxole 117 was synthesized by utilization of the cuprate 
methodology.  This was prepared using bromobenzene as discussed in Section 3.1 with 
the highest yield obtained being 36% (Scheme 32).  In previous investigations, the use of 
trimethylsilyl chloride (TMSCl) had resulted in an increase in the yields of the product 
obtained.  This has been explained by the silicon-containing reagent undergoing 
additional interactions with the enolates at the carbonyl oxygen because of the silicon’s 
affinity for oxygen.  This increases the nucleophilicity of the oxygen site and thus 
improves the electrophilic site for conjugate addition.50  The same interaction does not 
obtain with nitro compounds and therefore when TMSCl was omitted the yield obtained 
increased slightly to 55%.  Nonetheless, the organocuprate approach was thus abandoned 
due to low yields and the promising potential of the rhodium-catalysis method was 
pursued instead. 
 
When the rhodium-catalysis method for conjugate addition was employed the yield of 
compound 117 was increased to 68% and a ratio of 1:10 was attained for the minor 
diastereomer (syn-addition of phenyl) to that of the major diastereomer (anti-addition of 
the phenyl).  Flash column chromatography was necessary to ensure that the 
diastereomers were separated. Furthermore, the desired product became crystalline and a 
recrystalization was performed with diethyl ether for additional purification to afford 
clear rhombus-like crystals. 
 
In the 1H NMR spectrum of compound 117, the aromatic region 
was immediately observed to integrate for ten protons, suggesting 
that the addition of the phenyl substituent had been successful.  
The doublet peak at 5.92 ppm corresponding to the proton signal of H-3a was observed to 
be an excellent indicator for the presence of the diastereomer in mixed samples.  The 
presence of the diastereomer would show a second doublet appearing slightly upfield in 
the NMR spectrum.  The central region of the spectrum was unambiguously 
distinguishable, indicating clear coupling pertaining to the two H-2’ protons at 5.00 and 
4.72 ppm, both giving doublets of doublets with 2J of 12.8 Hz.  These in turn both 
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coupled to H-1’ which instead of the expected doublet of doublet of doublets, gave a 
doublet of triplets as a result of similar coupling constants between one of the H-2’ 
protons and the H-5–H-1’ coupling constants.  The two benzyl CH2 doublets were readily 
discernible and displayed geminal coupling to one another of 11.7 Hz.  When comparing 
the 13C NMR spectrum of compound 117 to that of the nitroalkene 105 (Chapter 2, 
section 2.3.2) the signal at 43.1 ppm (for C-1’) is a distinct confirmation of the presence 
of the phenyl adduct, in addition to the number of additional quaternary carbon and 
aromatic CH carbon signals. 
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A crystal structure was obtained, by X-ray diffraction (XRD) analysis, confirming that 
the (R)-product 117 had indeed been synthesized (Figure 14).  The crystallographic 
analysis of this structure afforded a satisfactory “goodness of fit” of 1.062 and an R factor 
of 3.3% for the orthorhombic crystal system in the P212121 space group.  Interesting 
features, such as the alignment of the bulky aromatic benzyl and phenyl groups to one 
another and other substituents in the structure could be observed.  Furthermore, the ring 
strain on the 5-membered furanose and its fused acetonide was noted.  The consequence 
on the geometry of substituents as a result of the ring strain was apparent and can be seen 
in Figure 14.   
 
 
Figure 14.  Molecular structure of 117 according to a single crystal X-ray analysis. 
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Having attained positive results for the phenyl aryl substituent 117, it was now necessary 
to attempt the conjugate addition using an aryl derivative that could better lead to the 
synthesis of pancratistatin 4.  Thus 3,4-dioxolylphenylboronic acid was used to 
synthesize compound 118, a glassy yellow pseudo-solid that when under the slightest 
influence of heat (≥ 35 °C) would melt into an oil (Scheme 32).  The TLC analysis of the 
reaction suggested that more than one product was being formed; however, a closer 
inspection of the spectra, obtained for the other isolated spots, suggested that the material 
was not a diastereomer, but rather some by-products. 
 
The 1H NMR spectrum obtained for compound 118, 
clearly indicated three downfield signals indicative of the 
dioxolylphenyl group.  The multiplet furthest downfield at 
7.38–7.23 ppm integrated for five aromatic hydrogens 
correlating to the benzyl ether protons as expected.  The 
second multiplet at 6.73–6.63 ppm integrated for three protons and correlated to the 
dioxolylphenyl aromatic protons H-4’’’, H-6’’’ and H-7’’’.  Finally, the signals at 5.92 
and 5.94 ppm were slightly overlapping and consisted of the H-2’’’ signal, which 
appeared to be two doublets, and then the expected H-3a signal with 3J coupling of 3.8 
Hz, which coincided with the expected doublet at 4.55 ppm for H-6a.  Similar couplings 
and chemical shifts to compound 117 were observed for the bulk of the spectrum.  The 
NOESY spectrum revealed an interaction between the H-5 proton and the aromatic 
hydrogens on the dioxolylphenyl substituent 118, which suggested that the aromatic 
group was indeed in the anti-conformation as anticipated in view of the fact that the 
stereochemistry of the H-5 proton had already been established previously.  Several 13C 
NMR spectrum signals attested to the presence of the addition product.  The aromatic CH 
carbon signals for the dioxolylphenyl ring were found at 121.6, 108.2, 108.1 and 106.6 
ppm.  The IR spectrum also showed the presence of new peaks at 1445 (CH bend) and 
1375 cm-1 (CO stretch), which indicated the presence of the oxygen substituents on the 
aromatic phenyl group.  The mass spectrum showed a molecular ion at m/z 443.1559 amu 
consistent with the formula C23H28O8N (calculated 443.1580 amu) further confirming the 
formation of the dioxolylphenyl conjugated 118. 
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The commercially available benzodioxineboronic acid was chosen for the synthesis of 
compound 119 because of its chemical similarity to the dioxolylphenyl aromatic 
substituent 118.  It was thus anticipated that it would react in a similar manner.  Although 
the reaction did occur the yield was unfortunately low when compared to compound 118 
(48% versus 84%).   
 
 In the 1H NMR spectrum for 6-((1R)-1-
{(3aR,5R,6R,6aR)-2,2-dimethyl-6-
[(phenylmethyl)oxy]tetrahydrofuro[2,3-d][1,3]dio
yl}-2-nitroethyl)-2,3
xol-5-
-dihydro-1,4-benzodioxine 119,  
the aromatic region accounted for an additional three 
protons at 6.78–6.74, corresponding to H-5’’’ and H-8’’’, and 6.70–6.64 ppm, 
corresponding to H-7’’’ of the compound.  When comparing the H-7’’’ signal to its 
counterpart in the somewhat similar dioxolylphenyl substituent 118, there has been a 
definite downfield shift, thus exposing the H-3a signal at 5.93 ppm.  The only other 
feature which was immediately obvious in the spectrum was the appearance of a singlet 
which integrated for four protons at 4.19 ppm, corresponding to the equivalent CH2 
groups on the benzodioxine structure.  Besides those two adequately corroboratory 
signals the remainder of the spectrum bore a remarkable resemblance to that seen 
previously with compound 118.  In the 13C NMR spectrum, the carbon signal 
corresponding to the CH2’s of the benzodioxine was clearly observed at 64.1 ppm.  The 
quaternary carbons making up the benzodioxine structure were also evident at 143.4 and 
143.4 ppm, as seen previously with the adduct 118.  Similarly, the IR spectrum 
reproduced many of the same peaks observed in 118, as expected due to their structural 
resemblance.  Nevertheless, evidence of new peaks at 1287 and 1207 cm-1 occurred, 
coinciding with the peaks associated with the aromatic ether.  High resolution mass 
spectrometry of the benzodioxine 119 (C24H27O8N) afforded a mass of 457.1715 amu, in 
good agreement with the expected value of 457.1737 amu. 
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Finally, in this section the 3,4,5-trimethoxyphenylboronic acid was used to synthesize 
compound 120.  The aryl substituent was envisaged as a precursor to a pancratistatin 
analogue because it contained similar functionality but posed interesting steric and 
structural diversity. However, the results were also poor (38%). 
 
(3aR,5R,6R,6aR)-2,2–Dimethyl-5-{(1R)-2-nitro-1-[3,4,5-
tris(methyloxy)phenyl]ethyl}-6-[(phenylmethyl) 
oxy]tetrahydrofuro[2,3-d][1,3]dioxole 120,  
was characterized in the associated 1H NMR spectrum by 
the appearance of three signals having been added to the 
spectrum, similar to that observed previously with the phenyl substituent 117.  The 
aromatic adduct possessed an axis of symmetry, and thus the aromatic hydrogens H-2’’’ 
and H-6’’’ were seen as equivalent and were therefore identified as a singlet at 6.41 ppm.  
The OMe aromatic substituents also gave singlets, one integrating for three protons, 
corresponding to the OMe (on C-4’’’) and one integrating for six protons, corresponding 
to the symmetrically equivalent, remaining OMe groups.  These signals occurred at 3.82 
and 3.69 ppm on the spectrum, respectively.  The remainder of the spectrum correlated to 
what was seen previously with the compound 117 and 118, with chemical shifts and 
coupling constants remaining relatively unchanged, despite the electronic influence of the 
aromatic adduct.  The 13C NMR spectrum clearly showed the quaternary carbons for C-
3’’’ and C-5’’’ at 153.3 ppm, where C-4’’’ gave a signal at 137.1 ppm.  The OMe signals 
also gave noteworthy signals further upfield in the spectrum at 60.8 and 56.1 ppm, which 
coincided with the signals at 3.82 and 3.69 ppm of 1H NMR spectrum; this was assigned 
using the CH correlated spectrum (HSQC). When comparing the IR spectrum for 
compound 120 to that of the nitroalkene 105, the spectrum undoubtedly indicated the 
appearance of two sharp peaks at 1243 and 1072 cm-1.  These peaks are in the region of 
aromatic ethers and are thus rather specific to this group.  The results of the high 
resolution mass spectrometry (HRMS) showed a molecular ion at 489.1985 amu, which 
was in close agreement with the expected molecular formula (C25H31O9N requires 
489.1999). 
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Despite several attempts the yields for addition products 119 and 120 could not be 
improved further.  It is unclear why the yields are low; it may be due to the different 
electronic effects of the substituents or even steric effects.  As a result the reactions were 
carried out for longer periods of time, ranging from three to six days, and in some cases 
heating of the system was attempted, ranging from room temperature to 80°C.  However, 
the results showed no significant effect on the yields of the final products.   
 
In conclusion, it was observed that the two approaches used for the conjugate addition of 
the aryl substituents were successful.  Owing to poor yields using the organocuprate 
method, only the phenyl adducts 115 and 117 were prepared using this approach.  It was 
shown that a variety of aromatic derivatives could be used for conjugate addition using 
the rhodium(I)-catalyzed approach due to the versatility of the methodology.  However, 
the yields achieved for these products ranged from 94 to 38%.  The major diastereomer 
was the sought after anti product. In the next chapter, an examination of different 
methods used for the ring closure of the cyclitol (ring C) will be done, while maintaining 
all the stereochemical structure already put into place.   
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CHAPTER 4:  RESULTS AND DISCUSSION  
ATTEMPTED RING CLOSURE 
 
As described in the previous chapter, the aromatic ring A was successfully introduced 
into the system by conjugate addition.  Accordingly, it was necessary to introduce the 
important contiguous stereocentres of the cyclitol ring of the pancratistatin ring C.  As 
described previously (Chapter 1, Section 1.4.3) Paulsen and Stubbe37,38 successfully 
obtained a deprotection of the acetal with the use of Dowex H+ resin in the presence of 
methanol, followed by the ring closure with sodium or potassium carbonate.  However, in 
the Paulsen and Stubbe synthesis additional rigidity was observed through lactone 
formation to give compound 64, from the ester substituent on the aromatic group (Scheme 
33).  Nonetheless, when considering our compounds the same chemical strategy was 
applied. 
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Scheme 33.  (i) K2CO3, MeOH, 34% over two steps. 
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4.1. Attempted ring closure using ester compound 115 
 
4.1.1. Attempted acetonide deprotection of the ester adduct 115 
 
The deprotection of the acetonide in compound 115 was performed under mildly acidic 
conditions as seen previously (Section 2.1.3); however, the Dowex H+ resin was used as a 
form of mild acid because it could easily be removed by filtration once the reaction was 
complete, resulting in a more efficient process.  It was surmised that the deprotection 
would expose the hemiacetal, and that equilibrium would be established between the diol 
121 and the aldehyde 122 of the deprotected open-chain tautomer (Scheme 34).  The 
deprotection was attempted on the phenyl adduct 115 only, due to the effort necessary for 
its preparation. 
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Scheme 34.  (i) Dowex H+ resin, MeOH, reflux–r.t. 
 
Initially, when the reaction was attempted, small amounts of starting material 115 
remained.  It was thus necessary to stir the reaction mixture under reflux until the reaction 
was complete, or the addition of more resin was required (3 times mass of starting 
material 115 versus 1.1 times used initially) in order to increase the acidity of the system.  
The reaction was therefore monitored by TLC to check for a change in polarity.  The Rf 
changed from 0.86 for the starting material 115, to 0.61 and 0.53 for the two spots of the 
presumed hemiacetal.   
 
A 1H NMR spectrum of the crude product was obtained in order to assess whether the 
hemiacetal had indeed formed.  Despite the central region of the spectrum showing vast 
complexity due to a mixture of products (starting material, diol and aldehyde), an 
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aldehyde singlet at 9.87 ppm appeared, in a very small ratio (~1:5) compared to the 
hemiacetal 121 (as expected because the equilibrium lies significantly toward the 
hemiacetal).  Another significant feature pertaining to the 1H NMR spectrum related to 
the H-3a proton signal at 5.95 ppm, which suggests the presence of the anomeric carbon 
C-3a of the hemiacetal.  However, because of the presence of the starting material in the 
compound causing ambiguity in the remaining peaks, no other defining conclusions could 
be drawn.  Unfortunately, all attempts at further purification of the product resulted in its 
complete decomposition.  It was therefore decided that the ring closure would be 
attempted on the crude product in an effort to gain the ring-closed product. 
 
4.1.2. Attempted cyclization of ring C using compound 122 
 
The ester approach toward the synthesis of pancratistatin produced very promising results 
up until the point of ring closure.  The proton α to the carbonyl (pKa ≈ 24.5) is far less 
acidic than that α to the nitro group (pKa ≈ 10).  A diversity of bases was thus attempted 
for the ring closure (Table 4.1); however, decomposition of the starting material did pose 
a problem, as observed previously when purification was attempted.  A diversity of 
reagents was also tested in an effort to improve the chances of cyclization (Scheme 35). 
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Scheme 35.  (i) See Table 4.1. for reagents and conditions. 
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Table 4.1.  Bases used for the attempted ring closure of ester 122. 
 
Reaction Reagents  Conditions pKa of conjugate acid46
1 K2CO3 MeOH, r.t., 48 h 10.2 
2 Et3N CH2Cl2, r.t., 72 h 10.7 
3 t-BuOK DMF, r.t., 48 h 18.0 
4 DBU CH3CN, r.t., 60 h 12.5 
 
Unfortunately, none of the attempts at cyclization into compound 123 afforded any 
substantial results and the spectra of the crude products were complex.  None of the final 
spectra for the above attempts coincided, suggesting that in some cases decomposition 
was highly likely; nonetheless in all the spectra the aromatic signal persisted as well as 
some other distinctly coupling peaks.  In spite of this, no conclusion could be drawn 
about what had formed in the product; it was felt that the complexity of the compound 
could be due to a mixture of diastereomers formed during the ring closure.  Therefore, it 
was decided that an acetyl protection of the putative cyclic product 123 could be 
undertaken in order to improve the spectral information and draw a clearer conclusion. 
 
4.1.3. Acetyl protection of the presumed cyclized ester product 123 
 
Approximately one equivalent of acetic anhydride and one equivalent of pyridine were 
added for every presumed hydroxyl group formed and the reaction mixture was left to stir 
at room temperature while being monitored by TLC (Scheme 36).  The TLC analysis 
proved rather promising as it demonstrated that one of the spots of high polarity (low Rf) 
had disappeared and a relatively prominent spot with a lower polarity began to feature 
strongly.   
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Scheme 36.  (i) Ac2O, pyridine, r.t., 48 h. 
 
The crude 1H NMR spectrum of proposed compound 124 suggested that three acetyl CH3 
singlets were present at 2.07, 2.06 and 2.04 ppm.  However, the bulk of the spectrum 
remained ambiguous and no further conclusions could be drawn.  Only slight changes in 
some of the chemical shifts of the more apparent signals such as H-3a seemed to appear 
at 6.44 ppm.  Also, a new singlet appeared at 6.14 ppm, which could not be accounted 
for.  This suggested that perhaps there could have been additional hydroxyl groups 
present but not as part of the sought after ring C.  All efforts at further purification 
resulted in decomposition or complete loss of the product.  The ester route was therefore 
discontinued and it was decided that all efforts would be concentrated on the nitro 
cyclization due to the close association with the Paulsen and Stubbe methodology.37,38  
 
4.2. Attempted ring closure using nitro compounds 
 
4.2.1. Attempted acetonide deprotection of nitro compounds 
 
The phenyl 122 and dioxolylphenyl 123 substrates prepared previously (Chapter 3), were 
used for the acetonide deprotection reactions.  Initially, the acetonide deprotection was 
thought to have occurred under the Dowex H+ resin conditions described previously (See 
page 73, Scheme 37).  However, from analysis of the 1H NMR spectrum, it was apparent 
that the two CH3 signals previously seen in the region of 1.50 and 1.40 ppm for the 
acetonide were no longer present.  However, after numerous repetitions of the experiment 
a pattern in the 1H NMR spectra became apparent, whereby a singlet at 3.44 ppm 
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appeared.  This indicated that the hemiacetal that was forming was reacting with the 
solvent, methanol, which was reacting at C-1 to form the new acetal 125 (Scheme 37).  
The signal for H-1 (δ = 5.04 ppm) gave a doublet which coupled to the adjacent H-2 at 
4.36 ppm.  The coupling constant of 4.4 Hz was suggestive of a cis relationship between 
H-1 and H-2.  Similarly, in the methyl-α-glucofuranoside anomer (or the cis isomer) 
reported in literature,75 a chemical shift value was observed at 4.52 ppm (in DMSO) 
which gave a coupling constant of 3.6 Hz.  Conversely, the methyl-β-glucofuranoside 
anomer (or trans isomer) at 4.38 ppm gave J value of 8.0 Hz.  This suggests that the 
anomer that was isolated was the methyl-α-glucofuranoside or the cis anomer.  Only one 
diastereomer was isolated 
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Scheme 37. (i) See Table 4.2. below for reagents and conditions. 
 
A brief literature survey suggested various other deprotection possibilities, which were 
attempted in the hope of overcoming this problem (Table 4.2).  All the experimental 
syntheses attempted in Table 4.2 were carried out on both the phenyl 117 and the 
dioxolylphenyl 118 adducts which were prepared previously in Chapter 3.  No reaction 
was observed for reactions 2 and 5 as evident from the 1H NMR spectra which indicated 
the presence of starting material as the only product.  This led to the understanding that 
deprotection conditions were perhaps too mild and it was necessary to activate the system 
further.  Unfortunately, reactions 6 and 7 seemed to have resulted only in decomposition 
of the starting material. 
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Table 4.2.  Various reaction conditions for the attempted acetonide deprotection reaction  
        of precursors 117 and 118. 
 
Reaction Reagents and conditions Reference 
 
1 
 
Dowex H+ resin, MeOH, reflux–r.t., 18 h 
 
37,38 
2 5M HCl, dioxane, r.t., 96 h 76 
3 CF3CO2H, H2O, r.t., 48 h 77 
4 75% CH3CN/H2O , conc. HCl, r.t., 96 h  
5 CF3CO2H, 4:1 THF/H2O, r.t., 12 h 78 
6 BCl3, CH2Cl2, r.t., 30 min 79 
7 80% AcOH, reflux-r.t., 1 h 80 
   
 
The NMR spectra of the product from reactions 3 and 4 showed the loss of the acetonide 
CH3 peaks and led to the hope of encouraging results.  The TLC analysis for reaction 4 
showed an increase in polarity, and the Rf value decreased remarkably to 0.14 from 0.64 
for precursor 117, and to 0.11 from 0.50 for precursor 118 (in 30% EtOAc/hexane).  No 
hydroxyl or aldehyde peaks could be seen in the 1H NMR spectra for reaction 3; 
however, the middle region of the spectra underwent significant peak broadening 
resulting in a disordered appearance, which could attest to hydroxyl peaks being hidden 
within the spectra.  Conversely, the 1H NMR spectra of reaction 4 exhibited a broad 
singlet integrating for two protons at 3.26 ppm, and although the spectra were not entirely 
distinct, some signals and their couplings could be seen.   
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4.2.2. Attempted cyclization of ring C using deprotected nitro compounds 
 
It was thus assumed that the various attempts at deprotection were successful and that the 
products were only complicated by the appearance of hydroxyl peaks causing additional 
peak broadening.  Most of the attempts on ring closure (Scheme 38) were made with the 
expectation that the acetonide deprotection occurred in the presence of Dowex H+ resin.  
The reaction progress was monitored by TLC (in eluent ranging from 50-100% 
AcOEt/hexane) which revealed highly polar products which did not migrate from the 
baseline.  This suggested that a salt was being formed during the reaction.  Further insight 
into the understanding of the possible mechanism was deduced and it was noted that 
potassium carbonate is a very weak base and probably not strong enough to perform the 
ring closure unaided.  It is also rather likely that the potassium carbonate will undergo 
additional transformations in methanol.  The emission of CO2(g) from the system could 
also induce KOH formation, which is also a basic substance.  Aqueous acid would be 
used in the work-up of the reaction to ensure that protonation of the products occurred.   
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Scheme 38.  (i) K2CO3, MeOH, r.t., 48 h.  Ar = Ph, dioxolylphenyl. 
 
The 1H NMR spectra for these experiments showed a diversity of complex products.  
Only the skeletal frame of the compound could still be seen, suggesting that the product 
had not succumbed entirely to decomposition.  Some interesting results were however 
observed with one of the dioxolylphenyl products in which the acetonide peaks 
disappeared from the 1H NMR spectrum and two very broad peaks at 2.87 and 2.01 ppm 
and two sharp singlets at 3.51 and 3.44 ppm were subsequently observed.  This could 
possibly suggest the presence of the hydroxyl groups in the compound; however, no other 
conclusions could be drawn.  In an attempt to further clarify the spectral data, an acetyl 
protection was selected. 
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4.2.3. Acetyl protection of the presumed cyclized nitro product 
 
The acetylation reaction (Scheme 39) was performed using the same methodology 
discussed in section 4.1.3 above.  The 1H NMR spectrum suggested that there was a 
mixture of products, due to the complexity of the spectrum.  Nonetheless, the two 
downfield peaks, most probably corresponding to H-3a, H-5 and H-6a appeared at 6.94 
and 6.67 ppm, both giving singlets which were suggestive of the presence of the protons 
adjacent to acetyl groups.  There was also evidence to suggest the presence of the acetyl 
peaks further upfield at 2.22, 1.99 and 1.97 ppm.  Various other anomalies were observed 
at 4.99, 3.66, 3.39, 3.33 ppm; all these signals gave singlets, which suggest a possible 
side-reaction with the acetyl onto other potential OH sites.  No further deductions could 
be made from this spectrum. Unfortunately, the in-house mass spectroscopy service was 
not available and could have possibly aided in the characterization of our desired product 
from within the crude mixture.  However, owing to time constraints the route was 
suspended at this point. 
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Scheme 39.  (i) Ac2O, pyridine, r.t., 96 h. 
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CHAPTER 5:  CONCLUSIONS AND FUTURE PROSPECTS 
 
5.1. Summary of results achieved 
 
Through chemistry which was previously established, the syntheses of both the nitro 
olefin 105 and the enoate 106 were successfully reproduced.  Further analysis into the 
stereochemistry of the products and their precursors was also accomplished in order to 
confirm the carbohydrate systems obtained. 
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Scheme 40. (i) CH3COCH3, I2, r.t., 20 h, 58%; (ii) NaH (65% in oil), Bu4NI, BnBr, THF, 
r.t., 22 h, 72%;. (iii) 50% acetic acid/H2O, r.t., 48 h, 76% or conc. HCl, MeOH, r.t., 96 h, 
78%; (iv) NaIO4, MeOH, H2O, 0°C–r.t.; (v) CH3NO2, Et3N, Et2O, 95% mixture of 
isomers; (vi) MeSO2Cl, Et3N, Et2O, 84%; (vii) methyl phosphonoacetate, NaH (60%), 
THF, 63% trans-106, 2% cis-106. 
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D-(+)-Glucose 58 was trapped in its furanose ring state 112 through a reaction with 
acetone, thus blocking the anomeric carbon from further reactivity (Scheme 40).  The 
acetone also protected four of the surrounding hydroxyl groups (as diol pairs) with 
acetonide protecting groups.  The remaining hydroxyl group then underwent a protection 
with benzyl bromide (BnBr) to form the benzyl ether 103.  A selective deprotection of the 
acetonide group containing the primary alcohol was carried out under mildly acidic 
conditions to give 113 in a reasonable yield of 78%.  An oxidation of the diol was 
induced with the aid of sodium periodate (NaIO4) to give the aldehyde intermediate 104.  
Finally, the aldehyde was used in two different syntheses.  The first produced the 
nitroalkene 105 from the Henry reaction.  The second route produced almost exclusively 
(E)-enoate 106 in 63% by the Horner-Wadsworth-Emmons reaction.  The intermediate 
step prior to achieving the nitroalkene 105 produced nitroalcohols 114a and 114b.  These 
isomers were analyzed in order to ascertain the stereochemistry of the major product.  
Despite the mixture of nitroalcohols the dehydration afforded the nitro olefin 105 in an 
84% yield as a single geometric isomer. 
 
The aim of performing the conjugate addition reactions utilizing two different approaches 
was to examine the stereochemical outcomes of the reaction.  Accordingly, the previously 
recorded data reported by Paulsen and Stubbe37,38 in 1983 were used as a basis of 
comparison and hence a foundation to improve upon. 
 
The organocuprate approach required a transmetallation of copper with a Grignard 
reagent to produce the reagent that was essential to the conjugate addition process.  The 
conjugate addition was only attempted using bromobenzene, thus producing the phenyl-
containing products 115 and 117 (Figure 15).  The resulting reactions were not highly 
efficient due to the preparation of the Grignard reagent being problematic and affording 
an insufficient amount of precursors necessary to attain the product.  Consequently, the 
yields of the product were somewhat low and the conjugate addition by the cuprate 
reagents was abandoned.   
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The rhodium-catalyzed induction of conjugate addition was found to be a highly atom 
economical reaction when compared to the organocuprate method.  The yields improved 
markedly, and because the aromatic precursor was a commercially available arylboronic 
acid, a variety of novel products could be produced.   
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Figure 15.  Aromatic analogues prepared by conjugate addition reactions. 
 
However, in the future, it would be profitable to expose both the enoate 106 and the 
nitroalkene 106 to organocuprate reactions using the same aromatic substituents as used 
in the rhodium-catalyzed method for conjugate addition (Figure 15).  In doing so a 
comparison and thus enhanced understanding of the two methods could be drawn.  
Nonetheless, from the data obtained in our synthesis it was shown that the anti product 
was highly selected for in both methods.  An approximate anti:syn ratio obtained for 
these aromatic additions was 14:1 for compounds 115 and 117 where the diastereomer 
could be isolated.   
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Despite an in-depth literature survey of numerous experimental methods for the 
deprotection of the acetonide group, all the attempts seemed to show that either no 
reaction had occurred, or that a complex mixture of products had formed, judging from 
the NMR spectra which were highly complex and difficult to analyse conclusively.  Our 
primary method, utilising Dowex H+ resin in methanol, showed the formation of  product 
125 (Figure 16), containing a methyl protected hydroxyl at the hemiacetal carbon, 
resulting in the method being discarded.   
 
O
OH
OMe
O2N
BnO
1
Ar
125  
Figure 16.  Compound 125, showing methyl protected hydroxyl group. 
 
The ring-closure was attempted using potassium carbonate and methanol under various 
experimental conditions.  However, all attempts at ring closure were inconclusive, as 
judged from the NMR of the crude products.  If the deprotection can be performed then 
the ring closure should occur quite readily for the nitro adducts due to acidity of the α-
carbon.   
5.2. Future prospects for the completion of the total synthesis 
 
Aspirations to produce pancratistatin 4 require the formation of ring B in pancratistatin as 
the final goal towards the completion of the total synthesis.  A brief literature survey has 
shown that a Bischler-Napieralski reaction has often been used for this purpose.25,28,41,42,81 
 
The nitro-containing compounds (the dioxolylphenyl adduct 126 was used to illustrate the 
synthesis in Scheme 41 as it directly generates deoxypancratistatin 5) would need to 
undergo a reduction with H2-Pd/C.46  Alternatively an aluminium amalgam could form 
the amine 127.  In the process of that reduction the remaining benzyl-protected hydroxyl 
group will probably also undergo a deprotection.  The amine will then be converted into 
the carbamate 128 which could be cyclized using a combination of 
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trifluoromethanesulfonic (triflic) anhydride (Tf2O) and 4-dimethylaminopyridine 
(DMAP) to yield deoxypancratistatin 5.25   
 
OHHO
OBn
NO2
OHO
O
OHHO
OH
NH2
OHO
O
OHHO
OH
NHCO2Me
OHO
O
OHHO
OH
NH
OHO
O
O
(i)
(ii)
(iii)
126 127
1285  
 
Scheme 41.  (i) H2/Pd/C or Al/Hg, EtOH/H2O; (ii) ClCO2Me, CH2Cl2, pyridine; (iii) 
Tf2O, DMAP. 
 
An alternative solution would be required when preparing the ester-containing 
compounds (Scheme 42).82  The ester 129 could be hydrolyzed to a carboxylic acid 130, 
which could then undergo the Curtius rearrangement reaction by treatment with 
diphenylphosphoryl azide (DPPA) in the presence of triethylamine (Et3N), to form an 
isocyanate 131.  This compound could be cyclized directly to deoxypancratistatin 5 using 
a Lewis Acid such as AlCl3, followed by the deprotection of the benzyl ether with H2-
Pd/C (Scheme 42). 
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Scheme 42.  (i) LiOH, THF; (ii) DPPA, Et3N, PhCH3 (iii) AlCl3; (iv) H2/Pd/C, 
EtOH/H2O. 
 
Although various aromatic substituents were prepared in order to produce a collection of 
pancratistatin analogues, the fundamental aim was to produce pancratistatin 4.  The only 
aromatic adduct resembling pancratistatin 4 at this juncture would be the dioxolylphenyl 
derivatives 116 and 118.  Therefore, it would be necessary to find a procedure to insert a 
hydroxyl into the C-7 position of the pancratistatin analogue (Scheme 43).  This was 
reported in 1997 by Haseltine and coworkers.40  Treatment of deoxypancratistatin with n-
butyllithium (n-BuLi) and borane in tetrahydrofuran (BH3.THF) would generate an 
intermediate arylborohydride, which could be oxidized with hydrogen peroxide (H2O2) to 
form the phenolic C-7 hydroxyl and finally pancratistatin 4.  Alternatively, the boronic 
acid 132 (Figure 17), could be prepared and used in the arylation reactions.83 
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Scheme 43. (i) n-BuLi, BH3.THF; (ii) H2O2, NaOH. 
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Figure 17.  7-hydroxybenzodioxolylboronic acid 132. 
 
In conclusion, the natural product D-(+)-glucose 58 was observed to be an efficient 
starting material for the stereochemical production of the α,β-unsaturated compounds 105 
and 106.  These olefins were also successfully used in both organocuprate and 
rhodium(I)-catalyzed conjugate addition of a variety of commercially available aryl 
substituents.  The desired anti stereochemistry was achieved in high ratios of 14:1.  
Despite the inconclusive evidence pertaining to the acetonide deprotection and ring 
closure for the prepared compounds, 115, 116, 117, 118, 119 and 120, the correct 
stereochemistry is in place for future synthetic attempts at the synthesis of pancratistatin 
4.   
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CHAPTER 6:  EXPERIMENTAL 
 
6.1. General procedures  
 
6.1.1. Purification of solvents  
 
All solvents used for preparative chromatography were distilled before use.  Unless 
otherwise stated, solvents used in reactions were pre-dried in their reagent bottles and 
then distilled over the appropriate drying mediums under a nitrogen atmosphere.  
Tetrahydrofuran (THF) and diethyl ether (Et2O) were distilled from sodium wire using 
benzophenone as an indicator.  Toluene (CH3Ph) was distilled from sodium metal lumps.  
Acetonitrile (CH3CN) and dichloromethane (CH2Cl2) were distilled from calcium 
hydride.  Pyridine was distilled from potassium hydroxide. 
 
6.1.2. Chromatography 
 
Separation of compounds by column chromatography was performed using Merck silica-
gel (particle size 0.063–0.200 mm) as an adsorbent.  Separation of compounds by flash 
column chromatography was performed using Merck silica-gel (particle size 0.04–0.063 
mm).  The Rf values quoted are for thin layer chromatography (TLC) on aluminum-
backed Merck silica-gel 60 F254 sheets.  Compounds on the TLC plates were either 
viewed under UV lights, by dipping the plates into basic potassium permanganate 
(KMnO4) or iodine absorbed onto silica. 
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6.1.3. Spectroscopic and physical data  
 
Melting points were obtained on a Reichert hot-stage microscope, and are uncorrected. 
 
Optical rotations were measured on a Jasco DIP 3-70 instrument at 22 °C at the sodium D 
line (589 nm), and [α]D values are given in deg.cm2.g-1. 
 
Infra-red spectra were recorded on Bruker Vector-22 Fourier Transform spectrometer or 
on a Bruker Tensor 27 Fourier Transform spectrometer. 
 
1H NMR and 13C NMR spectra were recorded either on a Bruker AVANCE 300 (300.13 
MHz) or on a Bruker DRX-400 (400.13 MHz) spectrometer.  All spectra were recorded 
in deuterated chloroform (CDCl3) and chemical shifts are reported in parts per million 
(ppm) relative to tetramethyl silane, the internal standard.  J values are given in hertz 
(Hz). 
 
High-resolution mass spectra were recorded either on a VG70 MS (Mass spectrum CC 
Pyramid data system) or on a VG70 SEQ (VG 11-205J or Marc 11 data system) or on a 
DFS High Resolution Magnetic Sector mass spectrometer. 
 
Intensity data were collected on a Bruker APEX II CCD area detector diffractometer with 
graphite monochromated Mo Kα radiation (50kV, 30mA) using the APEX 284 data 
collection software. The collection method involved ω-scans of width 0.5° and 512x512 
bit data frames. Data reduction was carried out using the program SAINT+.85  The crystal 
structure was solved by direct methods using SHELXTL.86 Non-hydrogen atoms were 
first refined isotropically followed by anisotropic refinement by full matrix least-squares 
calculations based on F2 using SHELXTL. Hydrogen atoms were first located in the 
difference map then positioned geometrically and allowed to ride on their respective 
parent atoms.  Diagrams and publication material were generated using SHELXTL, 
PLATON87 and ORTEP-3.88 
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6.1.4. Other general procedures  
 
All reactions were carried out under nitrogen using a standard manifold line connected to 
a vacuum pump.  The reaction vessels used were dried either in an oven or flame-dried 
whilst under vacuum.   
The term “in vacuo” refers to the removal of solvent under reduced pressure on a rotary 
evaporator followed by removal of trace amounts of solvent using a high vacuum (oil) 
pump. 
 
6.2. Experimental work pertaining to chapter 2  
 
6.2.1. (3aS,5R,6S,6aS)-5-[(4R)-2,2-Dimethyl-1,3-dioxolan-4-yl]-2,2-
dimethyltetrahydrofuro[2,3-d][1,3]dioxol-6-ol 112 
 
O
O
O
O
O
HO
3a
6a6
5
4'
5'
112 1
21'
1' 2'
1
 
 
D-(+)-glucose 58 (10.04 g, 55.2 mmol, 1 equiv.) was stirred in distilled acetone (400 
cm3) to give a white suspension, this was then followed by the addition of iodine (2.84 g, 
11.2 mmol, 0.2 equiv.), which immediately transformed the mixture to a brown colour.  
The suspension was stirred at room temperature, under an atmosphere of nitrogen, for 20 
hours.  The reaction mixture was quenched with a saturated solution of sodium 
thiosulfate (Na2S2O3), which was added slowly while stirring, until the brown colour 
disappeared.  The solvent was then evaporated and the product was extracted with ethyl 
acetate (AcOEt) (50 cm3), washed with water (3 × 50 cm3), then brine (50 cm3) and dried 
over anhydrous MgSO4.  The solvent was then removed in vacuo to give a white solid, 
which could be recrystalized with benzene to give compound 112 (8.42 g, 32.4 mmol, 
58%). 
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Rf: 0.83 (10% AcOEt/hexane); [α]D: –10.0 (c 2.0, CHCl3, 22 °C); M.p.: 112–114 °C, 
(literature57 109–110 °C); 1H NMR (300 MHz, CDCl3, δ/ppm): 5.94 (d, J = 3.6 Hz, 1H, 
H-3a), 4.53 (d, J = 3.6 Hz, 1H, H-6a), 4.38-4.30 (m, 1H, H-6, H-4’), 4.17 (dd, J = 8.6, 6.2 
Hz, 1H, H-5’), 4.07 (dd, J = 7.7, 2.7 Hz, 1H, H-5), 4.00 (dd, J = 8.6, 5.3 Hz, 1H, H-5’),  
2.76 (d, J = 3.8 Hz, 1H, OH), 1.50 (s, 3H, H-1’), 1.45 (s, 3H, H-1’), 1.37 (s, 3H, H-1), 
1.32 (s, 3H, H-1); 13C NMR (100 MHz, CDCl3, δ/ppm): 111.8 (C-2), 109.7 (C-2’), 105.3 
(C-3a), 85.1 (C-6a), 81.2 (C-5), 75.2 (C-6), 73.4 (C-4’), 67.7 (C-5’), 26.9 (C-1’), 26.8 (C-
1’), 26.2 (C-1), 25.2 (C-1); IR (υ/cm-1): 3424 (m, O-H stretch), 2984 (m, C-H stretch), 
1458 (w, C-H stretch), 1373 (m, C-H stretch), 1215 (s, O-H bend), 1000 (s, C-O stretch), 
845 (s, C-C stretch); HRMS (EI) [M–CH3]+: calculated for C11H17O6 245.1013 found 
45.1014; M/z (%): 245.1014 (100),241.2067 (11). 
 
,3-dioxolan-4-yl)-2,2-
dimethyl-tetrahydrofuro[2,3-d][1,3]dioxole 103 
 
2
6.2.2. (3aR,5R,6S,6aR)-6-(Benzyloxy)-5-(2,2-dimethyl-1
O
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Compound 112 (3.21 g, 12.3 mmol, 1 equiv.) was dissolved in distilled THF (160 cm3) 
and stirred at 0 °C under an atmosphere of nitrogen.  Sodium hydride (NaH) (60% in 
paraffin oil, 1.52 g, 37.0 mmol, 3 equiv.) was slowly added to the mixture, which began 
to turn a deep yellow colour, once deprotonation was complete.  Benzyl bromide (BnBr) 
(4.00 cm3, 2.47 mmol, 2.6 equiv.) and tetrabutylammonium iodide (Bu4NI) (0.910 g, 2.47 
mmol, 0.2 equiv.) were then added and the stirring mixture was allowed to warm to room 
temperature for 22 hours, were it became a deep yellow-orange opaque mixture.  The 
crude product was then quenched with acetic acid (AcOH) (2 cm3) and the solvent was 
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evaporated.  The organic layer was extracted with ethyl acetate (AcOEt) (50 cm3) and 
washed with water (3 × 50 cm3), then brine (50 cm3) and dried with MgSO4.  The solvent 
was evaporated under vacuum to produce a crude oil.  The oil was further purified by 
column chromatography (10% AcOEt/hexane) to afford a compound 103 as a pale yellow 
il (3.10 g, 8.85 mmol, 72%).   
 350.1726 (4), 341.0881 (1), 335.1488 (100, M–CH3+), 
32.1112 (2), 321.1463 (2). 
ssignments denoted by * are interchangeable 
 
o
 
Rf: 0.28 (10% AcOEt/hexane); [α]D: –22.5 (c 2.0, CHCl3, 22 °C); 1H NMR (300 MHz, 
CDCl3, δ/ppm): 7.36-7.30 (m, 5H, H-2”–H-6”), 5.89 (d, J = 3.6 Hz, 1H, H-3a), 4.68 (d, J 
= 11.8 Hz, 1H, H-1a”), 4.63 (d, J = 11.9 Hz, 1H, H-1b”), 4.58 (d, J = 3.7 Hz, 1H, H-6a), 
4.37 (td, J = 7.7, 6.0 Hz, 1H, H-4’), 4.17-4.08 (m, 2H, H-5, H-5’), 4.03-3.97 (m, 2H, H-6, 
H-5’), 1.49 (s, 3H, H-1’), 1.43 (s, 3H, H-1’), 1.37 (s, 3H, H-1), 1.31 (s, 3H, H-1); 13C 
NMR (100 MHz, CDCl3, δ/ppm): 137.6 (C-1”), 128.4 (C-2”, C-6”), 127.8 (C-4”), 127.6 
(C-3”, C-5”), 111.8 (C-2), 109.0 (C-2’), 105.3 (C-3a), 82.7 (C-6), 81.7 (C-6a), 81.3 (C-5), 
72.5 (C-1a”/b”), 72.4 (C-4’), 67.4 (C-5’), 26.8(C-1’), 26.8 (C-1’), 26.2(C-1), 25.4 (C-1); 
IR (υ/cm-1): 2986 (w, C-H stretch), 1541 (w, C=C stretch), 1372 (m, C-H stretch), 1212 
(m, C-O stretch), 1071 (s, C-O stretch); HRMS (EI): calculated for C19H23O6 350.1730 
found 350.1726; M/z (%):
3
 
A
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6.2.3. (1R)-1-{(3aR,5R,6R,6aR)-2,2-Dimethyl-6-
[(phenylmethyl)oxy]tetrahydrofuro[2,3-d][1,3]dioxol-5-yl}ethane-1,2-diol 113 
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Procedure 1: 
Compound 103 (4.8856 g, 13.94 mmol, 1 equiv.) was dissolved in a 50% acetic acid 
(AcOH) solution (100 cm3) and allowed to stir in an atmosphere of nitrogen over 48 
hours at room temperature.  The reaction mixture was diluted further in water (50 cm3) 
and treated with sodium hydrogen carbonate (NaHCO3) until the effervescence subsided. 
The product was then extracted with ethyl acetate (AcOEt) (3 × 50 cm3) and the organic 
extracts were combined and further washed with water (3 × 50 cm3), then brine (50 cm3).  
The organic extract was dried with MgSO4 and the solvent was evaporated.  The product 
was purified by column chromatography, initially with 10% AcOEt/hexane and then 
increasing the polarity by 5% every 100 cm3 until 50% AcOEt/hexane.  This afforded a 
pale yellow oil (3.2726 g, 10.5 mmol, 76%). 
 
Procedure 2: 
A solution of MeOH (470 cm3), distilled water (45 cm3) and concentrated HCl (2.5 cm3) 
was added to compound 103 (51 g, 145.5 mmol, 1 equiv.) and allowed to stir under an 
atmosphere of nitrogen for 96 hours, at room temperature.  The solution was neutralized 
with a NH4OH and the organic layer was extracted with ethyl acetate (AcOEt) (3 × 50 
cm3) and washed with water (3 × 50 cm3), followed by brine.  The organic layer was then 
dried over MgSO4 and the solvent was evaporated.  Purification of the crude product was 
done by column chromatography in 50% AcOEt/hexane, to give compound 113 as a pale 
yellow oil (35.33 g, 113.8 mmol, 78%). 
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Rf: 0.26 (10% AcOEt/hexane); [α]D: –50.8 (c 2.0, CHCl3, 22 °C); 1H NMR (300 MHz, 
CDCl3, δ/ppm):  7.39-7.25 (m, 5H, H-2”–H-6”), 5.92 (d, J = 3.8 Hz, 1H, H-3a), 4.71 (d, J 
= 11.8 Hz, 1H, H-1a”*), 4.61 (d, J = 3.8 Hz, 1H, H-6a), 4.56 (d, J = 11.8 Hz, 1H, H-
1b”*), 4.15-4.08 (m, 2H, H-5, H-6), 4.06-3.97 (m, 1H, H-4’), 3.84-3.74 (m, 1H, H-5’), 
3.73-3.63 (m, 1H, H-5’), 2.75 (d, J = 6.1 Hz, 1H, OH-2), 2.54 (t, J = 5.9 Hz, 1H, OH-1), 
1.48 (s, 3H, H-1), 1.31 (s, 3H, H-1); 13C NMR (100 MHz, CDCl3, δ/ppm): 138.1 (C-1”), 
129.5 (C-2”,C-6”), 129.0 (C-4”), 128.7 (C-3”, C-5”), 112.6 (C-2), 106.0 (C-3a), 83.0 (C-
6), 82.8 (C-6a), 80.8 (C-5), 73.0 (C-1a”/b”), 70.0 (C-4’), 65.2 (C-5’), 27.6 (C-1), 27.1 (C-
1); IR (υ/cm-1): 3423 (m br, O-H stretch), 2935 (w, C-H stretch), 1213 (m, O-H bend), 
1071 (s, C-O stretch), 885 (m, C-C stretch); HRMS (EI): calculated for C16H22O6 
310.1416 found 309.8962; M/z (%): 309.8962 (8), 306.0315 (3), 301.8138 (2), 296.2617 
(16), 295.1659 (100), 291.8672 (34). 
 
Assignments denoted by * are interchangeable 
 
6.2.4. (3aR,5S,6R,6aR)-2,2-Dimethyl-6-[(phenylmethyl)oxy]tetrahydrofuro[2,3-
d][1,3]dioxole-5-carbaldehyde 104 
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Compound 113 (5.04 g, 16.2 mmol, 1 equiv.) in MeOH (50 cm3) was cooled to 0 °C.  A 
solution of sodium periodate (NaIO4) (6.23 g, 29.1 mmol, 1.8 equiv.) in water (35 cm3) 
was then slowly added over 30 minutes.  A white precipitate began to form making the 
solution a thick emulsion, which was left to stir at room temperature for 18 hours, under 
an atmosphere of nitrogen.  The reaction was then diluted with water (200 cm3) to 
dissolve all the inorganic salts and the organic product was extracted with ethyl acetate 
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(AcOEt) (3 × 50 cm3).  The organic extracts were then collected and washed with brine (2 
× 50 cm3), dried (MgSO4) and the solvent was evaporated.  Compound 104 (crude yield: 
4.3384 g, 15.59 mmol, 96%) was used without further purification. 
 
Rf:  0.72 (50% AcOEt/hexane); [α]D:–49.0 (c 2.0, CHCl3, 22 °C); 1H NMR (300 MHz, 
CDCl3, δ/ppm): 9.67 (s, 1H, H-1’), 7.44–7.18 (m, 5H, H-2”–H-6”), 6.12 (d, J = 3.3 Hz, 
1H, H-3a), 4.93–4.00 (m, 4H), 3.51–3.40 (m, 1H), (s, 3H, H-1), 1.33 (s, 3H, H-1); IR 
(υ/cm-1): 2936 (m, C-H stretch), 1738 (m, C=O stretch), 1072 (s, C-O stretch). 
 
6.2.5. Methyl (2E)-3-{(3aR,5R,6R,6aR)-2,2-dimethyl-6-
[(phenylmethyl)oxy]tetrahydrofuro[2,3-d][1,3]dioxol-5-yl}prop-2-enoate 106 
 
 
Sodium hydride (NaH) in 60% paraffin oil (0.75 g, 18.7 mmol, 1.3 equiv.) in THF (50 
cm3) was cooled to –60 °C.  Trimethyl phosphonoacetate (2.6 cm3, 18.0 mmol, 1.25 
equiv.) was slowly added, and the mixture was then left to warm to room temperature for 
1 hour.  The reaction vessel was then recooled to –60 °C and compound 104 (4.0 g, 14.4 
mmol, 1 equiv.) in THF (20 cm3) was added to stirring mixture.  The reaction was again 
allowed to warm to room temperature and left to stir under an atmosphere of nitrogen for 
20 hours.  The reaction was quenched with solid ammonium chloride (NH4Cl) (2.5 g, 
4.67 mmol, 3.26 equiv.) and poured into water (100 cm3).  The product was extracted 
with ethyl acetate (AcOEt) (3 × 50 cm3) and the combined organic extracts were washed 
with brine (2 × 50 cm3), dried over MgSO4 and the solvent was then removed in vacuo to 
give a crude product.  Flash chromatography was prepared in 20% AcOEt/hexane, to give 
the major E-isomer, compound trans-106 as a pale yellow oil (3.7603 g, 11.2 mmol, 
78%) and the minor Z-isomer, compound cis-106 (0.5359 g, 1.60 mmol, 11%). 
Rf: trans-106: 0.33, cis-106: 0.42 (20% AcOEt/hexane); [α]D: trans-106: –92.5, cis-106: 
–58.5 (c 2.0, CHCl3, 22 °C). 
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1H NMR (300 MHz, CDCl3, δ/ppm) trans-106: 7.44–7.16 
(m, 5H, H-2”–H-6”), 6.96 (dd, J = 15.8, 5.0 Hz, 1H, H-3’), 
6.17 (dd, J = 15.8, 1.7 Hz, 1H, H-2’), 5.99 (d, J = 3.7 Hz, 
1H, H-3a), 4.79 (ddd, J = 5.0, 3.3, 1.7 Hz, 1H, H-5), 4.63 (d, 
J = 3.3 Hz, 1H, H-6a), 4.61 (d, J = 12.5 Hz, 1H, H-1a”*), 
4.49 (d, J = 12.2 Hz, 1H, H-1b”*), 3.97 (d, J = 3.01 Hz, 1H, 
H-6), 3.75 (s, 3H, H-1’), 1.48 (s, 3H, H-1), 1.32 (s, 3H, H-1); 
13C NMR (100 MHz, CDCl3, δ/ppm): 166.8 (C-1a’), 142.2 (C-3a’), 137.5 (C-1”), 128.9 
(C-2”, C-6”), 128.5 (C-4”), 128.2 (C-3”, C-5”), 123.2 (C-2’), 112.3 (C-2), 105.4 (C-3a), 
83.3 (C-6), 83.2 (C-6a), 79.8 (C-5), 72.6 (C-1a”/b”), 52.1 (C-1’), 27.2 (C-1), 26.6 (C-1); 
IR (υ/cm-1): 2989 (w, C-H stretch), 1720 (s, C=O stretch), 1438, 1374 (m, C-H bend), 
1201, 1072 (s, C-O stretch), 855 (m, C-C stretch); HRMS (EI) [M–CH3]+: calculated for 
C17H19O6 319.1169 found 319.1177; M/z (%): 319.1177 (100), 316.9829 (88), 309.9818 
(20), 302.9857 (9). 
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1H NMR (300 MHz, CDCl3, δ/ppm) cis-106:  7.36–7.21 (m, 5H, 
H-2”–H-6”), 6.40 (dd, J = 11.7, 6.7 Hz, 1H, H-3’), 6.01 (d, J = 
3.5 Hz, 1H, H-3a), 5.93 (dd, J = 11.8, 1.7 Hz, 1H, H-2’), 5.65 
(ddd, J = 6.8, 3.3, 1.7 Hz, 1H, H-5), 4.64 (d, J = 3.5 Hz, 1H, H-
6a), 4.61 (d, J = 11.8 Hz, 1H, H-1a”*), 4.45 (d, J = 12.0 Hz, 1H, 
H-1b”*), 4.29 (d, J = 3.3 Hz, 1H, H-6), 3.66 (s, 3H, H-1’), 1.52 
(s, 3H, H-1), 1.33 (s, 3H, H-1). 
O
O
O
O
3a
6a6
5
1a"
1b"
cis-106
2 1
1
1"2"
3"
4" 5"
6"
O
O
1'
1a'2'
3'
 
Assignments denoted by * are interchangeable 
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6.2.6. (1S) and (1R)-1-{(3aR,5R,6R,6aR)-2,2-Dimethyl-6-
[(phenylmethyl)oxy]tetrahydrofuro[2,3-d][1,3]dioxol-5-yl}-2-nitroethanol 
114a and 114b 
 
Triethylamine (Et3N) (1.40 cm3, 10.9 mmol, 1.2 equiv.) was added to a stirring mixture 
of aldehyde 104 (2.52 g, 9.20 mmol, 1 equiv.) in nitromethane (MeNO2) (15 cm3) and left 
to stir at room temperature for 24 hours under an atmosphere of nitrogen.  The solvents 
were then evaporated under reduced pressure.  The product was preabsorbed onto silica 
and purified by column chromatography by increasing the polarity from 5 to 20% 
AcOEt/hexane.  The major α-D-gluco isomer 114a was collected as a pale yellow oil 
(2.2702 g, 6.67 mmol, 73%) and the minor β-L-ido isomer 114b was collected as an 
opaque white oil (0.2979 g, 0.875 mmol, 9.5%).   
 
Isomeric ratio: 8: 1; de: 63% ; Rf: 114a: 0.44 , 114b: 0.33 (30% AcOEt/hexane); M.p.: 
114b: 90–92 °C;  [α]D: 114a: –37.0, 114b: –51.9 (c 2.0, CHCl3, 22 °C); IR (υ/cm-1): 
3449 (m, O-H stretch), 1548 (s, N-O stretch), 1380 (m, C-H bend), 1210 (m, O-H bend), 
1027 (s, C-O stretch), 850 (C-C stretch); HRMS (EI) [M–CH3]+: calculated for 
C15H18O7N 324.1071 found 324.1077; M/z (%): 324.1077 (100), 322.2507 (9), 316.9827 
(30). 
 
1H NMR (300 MHz, CDCl3, δ/ppm) 114a: 7.42–7.30 (m, 5H, H-
2”–H-6”), 5.91 (d, J = 3.6 Hz, 1H, H-3a), 4.74 (d, J = 11.7 Hz, 
1H, H-1a”*), 4.63 (d, J = 3.7 Hz, 1H, H-6a), 4.79–4.59 (m, 2H, 
H-1’, H-2’), 4.53 (d, J = 11.8 Hz, 1H, H-1b”*), 4.46 (dd, J = 
13.1, 8.9 Hz, 1H, H-2’), 4.12–4.06 (m, 1H, H-5), 4.07 (d, J = 
3.38 Hz, 1H, H-6), 2.64 (d, J = 5.5 Hz, 1H, OH), 1.47 (s, 3H, H-
1), 1.32 (s, 3H, H-1); 13C NMR (100 MHz, CDCl3, δ/ppm): 136.9 (C-1”), 128.8 (C-2”, 
C-6”), 128.3 (C-4”), 127.9 (C-3”, C-5”), 112.1 (C-2), 105.2 (C-3a), 81.9 (C-6), 81.0 (C-
6a), 80.0 (C-5), 78.6 (C-2’), 72.1 (C-1a”/b”), 66.3 (C-1’), 26.7 (C-1), 26.1 (C-1). 
O
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1H NMR (300 MHz, CDCl3, δ/ppm) 114b: 7.42–7.29 (m, 5H, 
H-2”–H-6”), 6.00 (d, J = 3.7 Hz, 1H, H-3a), 4.75 (d, J = 11.8 
Hz, 1H, H-1a”*), 4.67 (d, J = 3.8 Hz, 1H, H-6a), 4.78–4.62 (m, 
1H, H-1’), 4.50 (d, J = 11.8 Hz, 1H, H-1b”*), 4.50 (dd, J = 11.8, 
3.2 Hz, 1H, H-2’), 4.33 (dd, J = 12.8, 3.2 Hz, 1H, H-2’), 4.17 (t, 
J = 4.1 Hz, 1H, H-5), 4.09 (d, J = 3.9 Hz, 1H, H-6), 3.34 (s, 1H, 
OH), 1.47 (s, 3H, H-1), 1.34 (s, 3H, H-1); 13C NMR (100 MHz, CDCl3, δ/ppm): 136.1 
(C-1”), 128.8 (C-2”, C-6”), 128.6 (C-4”), 128.1 (C-3”, C-5”), 112.3 (C-2), 105.0 (C-3a), 
82.6 (C-6), 82.2 (C-6a), 79.1 (C-5), 77.6 (C-2’), 72.0 (C-1a”/b”), 67.7 (C-1’), 26.8 (C-1), 
26.3 (C-1). 
O
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6.2.7. (3aR,5R,6R,6aR)-2,2-Dimethyl-5-[(E)-2-nitroethenyl]-6-
[(phenylmethyl)oxy]tetrahydrofuro[2,3-d][1,3]dioxole 105 
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Compound 114a (7.75 g, 22.79 mmol, 1 equiv.) was dissolved in diethyl ether (Et2O) (70 
cm3) and stirred at 0 °C.  Methylsulfonylchloride (MeSO2Cl) (3 cm3) and Et2O (50 cm3) 
were added to a dropping funnel and added to the stirring mixture over 45 minutes, the 
mixture was then left to stir for an additional 30 minutes.  The reaction vessel was then 
allowed to warm to room temperature and left to stir under an atmosphere of nitrogen for 
36 hours.  The reaction was quenched with 5 % HCl (250 cm3), extracted with ethyl 
acetate (AcOEt) (3 × 50 cm3) and washed the organic layer with brine (3 × 50 cm3), dried 
over MgSO4 and then the solvents were evaporated under reduced pressure.  The crude 
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product was purified by flash chromatography in 25% AcOEt/hexane to give a deep 
yellow oil as compound 105 (6.12 g, 19.1 mmol, 84%). 
 
Rf: 0.47 (25% AcOEt/hexane); [α]D: –24.5 (c 2.0, CHCl3, 22 °C); 1H NMR (300 MHz, 
CDCl3, δ/ppm): 7.39–7.20 (m, 6H, H-2”–H-6”, H-2’ *), 7.16 (dd, J = 13.3, 3.5 Hz, 1H, 
H-1’ *), 5.99 (d, J = 3.6 Hz, 1H, H-3a), 4.90 (dt, J = 3.5, 1.3 Hz, 1H, H-5), 4.66 (d, J = 
11.7 Hz, 1H, H-1a” #), 4.67 (d, J = 3.9 Hz, 1H, H-6a), 4.46 (d, J = 12.1 Hz, 1H, H-1b” #), 
4.05 (d, J = 3.4 Hz, 1H, H-6), 1.49 (s, 3H, H-1), 1.34 (s, 3H, H-1); 13C NMR (100 MHz, 
CDCl3, δ/ppm): 140.9 (C-1’), 136.6 (C-2’), 135.8 (C-1”), 128.6 (C-2”, C-6”), 128.3 (C-
4”), 127.8 (C-3”, C-5”), 112.3 (C-2), 105.1 (C-3a), 82.4 (C-6), 82.3 (C-6a), 72.2 (C-
1a”/b”), 66.8 (C-5), 26.8 (C-1), 26.1 (C-1); IR (υ/cm-1): 2938 (w, C-H stretch), 1662 (w, 
C=C stretch), 1526 (s, N-O stretch), 1354 (m, C-H bend), 1075 (s, C-O stretch); HRMS 
(EI) [M–CH3]+: calculated for C15H16O6N 306.0865 found 306.0983; M/z (%): 
306.0983 (100), 304.1012 (9), 298.0362 (4), 291.0794 (9). 
 
Assignments denoted by * and # are interchangeable 
 
6.3. Experimental work pertaining to chapter 3 
 
General procedure for cuprate mediated conjugate additions: 
A three-necked round bottom flask equipped with a rubber septum, containing 
magnesium turnings, was flame dried under vacuum.  THF (10 cm3) was added followed 
by the slow addition of bromobenzene (PhBr) (10 equiv.) in THF (10 cm3), which 
induced a highly exothermic reaction.  The reaction was left to cool to room temperature 
once the reaction stopped, and was left to stir under an atmosphere of nitrogen for 1 hour 
until the mixture changed to a grey-yellow colour.  In a second flame-dried three-necked 
flask, cuprous iodide (CuI) (5 equiv.) in THF (20 cm3) was cooled to –78 °C.  The 
previously prepared Grignard reagent was then cannulated to the cooled cuprate solution 
and allowed to warm to room temperature for 3 hours.  The reaction vessel was again 
cooled to –78 °C and unsaturated alkene (1 equiv.) in THF (30 cm3) was then cannulated 
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to the organocuprate mixture, which caused the mixture to turn opaque yellow in 
appearance.  The reaction mixture was left to warm to room temperature and left to stir in 
an atmosphere of nitrogen for 20 hours.  The reaction appeared to have changed a brown 
colour overnight.  The reaction was quenched with 10% NH4OH/NH4Cl solution (in 
water).  The organic phase was extracted with ethyl acetate (AcOEt) (3 × 50 cm3), 
washed with water (2 × 50 cm3) and brine (50 cm3).  The organic extract was dried over 
MgSO4, filtered and evaporated under reduced pressure.  The crude product was purified 
by column chromatography (20% AcOEt/hexane) to afford the product. 
Trimethylsilyl chloride (TMSCl, 10.0 equiv.) was used to prepare the propanoate 
derivative 115.  TMSCl (10 equiv.) was cannulated along with the enoate (1 equiv.) and 
THF (30 cm3). 
 
General procedure for rhodium-catalyzed conjugate additions:  
 
Phenylboronic acid (2 equiv.) and {[(cod)RhCl]2} catalyst (3% mol equiv.) were added to 
a stirring mixture of nitroalkene 105 or enoate 106 (1 equiv.), in a 10:1 dioxane/H2O 
mixture (25 cm3).   After 5 minutes of stirring at room temperature, triethylamine (Et3N) 
(1.2 equiv.) was added to the reaction, which changed in appearance from yellow-orange 
in colour to dark red-brown in colour.  The system was left to stir at room temperature, 
under nitrogen, for 5 days.  The solvents were removed in vacuo, the product was then 
preabsorbed onto silica and purified by flash column chromatography (20% 
AcOEt/hexane) to afford the product.   
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6.3.1. Methyl (3S)-3-{(3aR,5R,6R,6aR)-2,2-dimethyl-6-
[(phenylmethyl)oxy]tetrahydrofuro[2,3-d][1,3]dioxol-5-yl}-3-
phenylpropanoate 115 
 
Major diasteriomer 115 afforded a clear yellow oil (0.271 g, 0.657 mmol, 55%) achieved 
for the cuprate conjugate addition reaction and (0.261 g, 0.632 mmol, 94%) achieved for 
the rhodium catalyzed conjugate addition.  Rf: 115: 0.53, 115b: 0.47 (30% 
AcOEt/hexane); [α]D: 115 –29.5, 115b: –43.0 (c 2.0, CHCl3, 22 °C 3); IR (υ/cm-1): 2990 
(w, C-H stretch), 1738 (s, C=O stretch), 1498, 1375 (w, C-H bend), 1073, 1016 (s, C-O 
stretch); ); HRMS (EI): calculated for C24H28O6 412.1886 found 412.1791; M/z (%): 
412.1791 (7), 410.0845 (1), 402.9792 (1), 399.1676 (4), 398.1644 (26), 397.1654 (100, 
M–CH3+), 395.1725 (2). 
 
1H NMR (300 MHz, CDCl3, δ/ppm) 115: 7.36-7.21 (m, 10H, 
H-2”–H-6”, H-2’’’–H-6’’’), 5.95 (d, J = 3.8 Hz, 1H, H-3a), 
4.52 (d, J = 3.8 Hz, 1H, H-6a),  4.39 (d, J = 11.6 Hz, 1H, 
1a”*), 4.38 (dd, J = 10.2, 3.5 Hz, 1H, H-5), 4.10 (d, J = 11.4 
Hz, 1H, H-1b”*),  3.71 (dt, J = 10.5, 4.3 Hz, 1H, H-3’), 3.48 
(s, 3H, H-1’), 3.44 (d, J = 3.0 Hz, 1H, H-6), 3.11 (dd, J = 
15.6, 4.3 Hz, 1H, H-2’), 2.69 (dd, J = 15.6, 10.6 Hz, 1H, H-2’), 1.53 (s, 3H, H-1), 1.30 (s, 
3H, H-1); 13C NMR (100 MHz, CDCl3, δ/ppm): 172.3 (C-1a’), 140.2 (C-1’’’), 137.2 (C-
1”), 128.3 (C-2”, C-6”), 128.2 (C-2’’’, C-6’’’), 128.1 (C-3”, C-5”), 127.6 (C-4’), 127.5 
(C-3’’’, C-5’’’), 126.8 (C-4’’’), 111.2 (C-2), 104.9 (C-3a), 83.2 (C-5), 81.8 (C-6a), 81.5 
(C-6), 71.8 (C-1a”/b”), 51.1 (C-1’), 40.7 (C-3’), 38.6 (C-2’), 26.6 (C-1), 26.0 (C-1). 
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1H NMR (300 MHz, CDCl3, δ/ppm) 115b: 7.42-7.16 (m, 
10H, H-2”–H-6”, H-2’’’–H-6’’’), 5.87 (d, J = 3.9 Hz, 1H, H-
3a), 4.75 (d, J = 11.9 Hz, 1H, H-1a”*), 4.64 (d, J = 3.9 Hz, 
1H, H-6a), 4.47 (d, J = 11.9 Hz, 1H, H-1b”*), 4.36 (dd, J = 
9.7, 3.0 Hz, 1H, H-5), 3.89 (d, J = 3.0 Hz, 1H, H-6), 3.67 
(dt, J = 9.7, 4.6 Hz, 1H, H-3’), 3.48 (s, 3H, H-1’), 2.54 (dd, J 
= 15.2, 9.9 Hz, 1H, H-2’), 2.45 (dd, J = 15.2, 4.6 Hz, 1H, H-2’), 1.47 (s, 3H, H-1), 1.29 
(s, 3H, H-1
O
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). 
 
Assignments denoted by * are interchangeable 
 
6.3.2. Methyl (3S)-3-{(3aR,5R,6R,6aR)-2,2-dimethyl-6-
[(phenylmethyl)oxy]tetrahydrofuro[2,3-d][1,3]dioxol-5-yl}-3-(1,3-
benzodioxol-5-yl)propanoate 116 
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Clear yellow oil (0.10 g, 0.22 mmol, 26%) for the rhodium catalyzed conjugate addition.  
Rf: 0.47, (30% AcOEt/hexane); [α]D: –37.5 (c 2.0, CHCl3, 22 °C); 1H NMR (300 MHz, 
CDCl3, δ/ppm): 7.38-7.24 (m, 5H, H-2”–H-6”), 6.74-6.67 (m, 3H, H-4’’’, H-6’’’, H-7’’’), 
5.98-5.87 (m, 2H, H-2’’’, H-3a), 4.53 (d, J = 3.8 Hz, 1H, H-6a), 4.44 (d, J = 11.3 Hz, 
1H, H-1a”*), 4.26 (dd, J = 10.4, 2.9 Hz, 1H, H-5), 4.16 (d, J = 11.3 Hz, 1H, H-1b”*), 
3.60 (dt, J = 10.7, 4.2 Hz, 1H, H-3’), 3.52 (s, 3H, H-1’), 3.47 (d, J = 2.9 Hz, 1H, H-6), 
3.06 (dd, J = 15.6, 4.2 Hz, 1H, H-2’), 2.61 (dd, J = 15.6, 10.8 Hz, 1H, H-2’), 1.51 (s, 3H, 
H-1), 1.30 (s, 3H, H-1); 13C NMR (100 MHz, CDCl3, δ/ppm): 172.5 (C-1a’), 147.6 (C-
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3a’’’#), 146.4 (C-7a’’’#), 137.3 (C-5’’’), 134.0 (C-1”), 128.4 (C-2”, C-6”, C-4”), 127.9 
(C-3”, C-5”), 121.5 (C-4’’’), 111.5 (C-2), 108.5 (C-6’’’), 108.2 (C-7’’’), 105.0 (C-3a), 
100.9 (C-2’’’), 83.4 (C-5), 81.9 (C-6a), 81.6 (C-6), 72.1 (C-1a”/b”), 51.4 (C-1’), 40.5 (C-
3’), 38.8 (C-2’), 26.8 (C-1), 26.2 (C-1); IR (υ/cm-1): 2988 (w, C-H stretch), 1734 (s, C=O 
stretch), 1504 (m, C=C stretch) 1440, 1373 (m, C-H bend), 1244 (s, C-C stretch), 1163 
(m, C-C stretch), 1071, 1025 (s, C-O stretch); HRMS (EI): calculated for C25H28O8 
456.1784 found 456.1762; M/z (%): 456.1762 (100), 452.9756 (1), 443.9760 (2), 
441.1078 (6), 435.9735 (1), 431.9772 (1). 
  
Assignments denoted by * and # are interchangeable 
 
6.3.3. (3aR,5R,6R,6aR)-2,2-Dimethyl-5-[(1R)-2-nitro-1-phenylethyl]-6-
[(phenylmethyl)oxy]tetrahydrofuro[2,3-d][1,3]dioxole 117 
 
The major diasteriomer 117 was isolated as white crystals (1.29 g, 3.23 mmol, 55%) for 
cuprate conjugate addition and (0.210 g, 0.526 mmol, 68%) for the rhodium catalyzed 
conjugate addition.  Rf: 117: 0.55, 117b: 0.44 (30% AcOEt/hexane); M.p.: 117: 116 °C; 
[α]D: 117 –26.8 (c 2.0, CHCl3, 22 °C); IR (υ/cm-1): 3033 (w, C-H stretch), 1554 (s, N-O 
stretch), 1383 (m, C-H bend), 1221, 1164 (m, C-C stretch), 1067 (s, C-O stretch); HRMS 
(EI): calculated for C22H25NO6 399.1682 found 400.9868; M/z (%): 400.9868 (100), 
399.0050 (28), 397.9859 (8), 393.9712 (10), 391.9734 (2), 390.9791 (14), 388.9664 (4), 
386.9540 (8), 385.9596 (15), 384.9556 (26), 382.9743 (16), 379.9894 (4). 
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1H NMR (300 MHz, CDCl3, δ/ppm) 117: 7.39-7.19 (m, 
10H, H-2”–H-6”, H-2’’’–H-6’’’), 5.95 (d, J = 3.7 Hz, 1H, 
H-3a), 5.00 (dd, J = 12.8, 4.4 Hz, 1H, H-2’), 4.72 (dd, J = 
12.7, 10.8 Hz, 1H, H-2’), 4.54 (d, J = 3.8 Hz, 1H, H-6a), 
4.44 (d, J = 11.5 Hz, 1H, H-1a”*), 4.40 (dd, J = 10.1, 3.2 
Hz, 1H, H-5), 4.15 (d, J = 11.3 Hz, 1H, H-1b”*), 4.03 (dt, J 
= 10.4, 4.4 Hz, 1H, H-1’), 3.53 (d, J = 3.00 Hz, 1H, H-6), 1.50 (s, 3H, H-1), 1.30 (s, 3H, 
H-1); 13C NMR (100 MHz, CDCl3, δ/ppm): 136.9 (C-1’’’), 136.5 (C-1’), 128.8 (C-2’’’, 
C-6’’’), 128.5 (C-2”, C-6”), 128.1 (C-4”, C-4’’’), 128.0 (C-3’’’, C-5’’’), 127.7 (C-3”, C-
5”), 111.7 (C-2), 105.1 (C-3a), 81.6 (C-6a), 81.5 (C-6), 81.2 (C-5), 78.7 (C-2’), 72.1 (C-
1a”/b”), 43.0 (C-1’), 26.7 (C-1), 26.0 (C-1); X-ray data:  C22H25NO6; M=399.43; 
Orthorhombic; 0.71073 Å; a=8.90410(10) Å, b=10.2774(2) Å, c=22.5111(4) Å, 
U=2060.01(6) Å3, 173(2) K, space group, P212121, Z=4; μ(Mo-Kα)=0.094 mm-1 46960 
reflections measured.  Final R indices [I>2σ(I)] R1=0.0327, wR(F2)=0.0846. 
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1H NMR (300 MHz, CDCl3, δ/ppm) 117b: 7.45-7.17 (m, 
10H, H-2”–H-6”, H-2’’’–H-6’’’), 5.92 (d, J = 3.9 Hz, 1H, 
H-3a), 4.79 (dd, J = 13.2, 10.1 Hz, 1H, H-2’), 4.71 (d, J = 
11.7 Hz, 1H, H-1a”*), 4.64 (dd, J = 13.2, 4.1 Hz, 1H, H-2’), 
4.63 (d, J = 3.9 Hz, 1H, H-6a), 4.45 (d, J = 11.7 Hz, 1H, H-
1b”*), 4.39 (dd, J = 7.7, 3.1 Hz, 1H, H-5), 4.09 (ddd, J = 
10.0, 7.7, 4.1 Hz, 1H, H-1’), 3.81 (d, J = 3.1 Hz, 1H, H-6), 1.47 (s, 3H, H-1), 1.30 (s, 3
O
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-1). 
ssignments denoted by * are interchangeable 
 
H
 
A
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6.3.4. 5-((1R)-1-{(3aR,5R,6R,6aR)-2,2-Dimethyl-6-
[(phenylmethyl)oxy]tetrahydrofuro[2,3-d][1,3]dioxol-5-yl}-2-nitroethyl)-1,3-
benzodioxole 118 
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(C-1); IR (υ/cm-1): 2988 (w, C-H stretch), 
51 (s, N-O stretch) 1490, 1376 (m, C-H bend), 1248 ((m, C-C stretch), 1163 (m, C-C 
tretch), 1071, 1024 (s, C-O stretch); HRMS (EI): calculated for C23H25O8N 443.1580 
 (30), 435.9738 (17), 428.9794 (60), 
23.9732 (23), 417.9779 (10), 414.9768 (17). 
angeable 
 
7a''' 7'''
 
 
Clear yellow oil (0.496 g, 1.12 mmol, 84%) for the rhodium-catalyzed conjugate 
addition.  Rf: 0.33, minor:(30% AcOEt/hexane); [α]D: –31.5 (c 2.0, CHCl3, 22 °C); 1H 
NMR (300 MHz, CDCl3, δ/ppm): 7.38-7.23 (m, 5H, H-2”–H-6”), 6.73-6.63 (m, 3H, H-
4’’’, H-6’’’, H-7’’’), 5.92 (dd, J = 3.1, 1.4 Hz, 2H, H-2’’’)  5.94 (d, J = 3.8 Hz, 1H, H-
3a), 4.95 (dd, J = 12.7, 4.4 Hz, 1H, H-2’), 4.64 (dd, J = 12.4, 11.1 Hz, 1H, H-2’), 4.55 (d, 
J = 3.8 Hz, 1H, H-6a), 4.48 (d, J = 11.3 Hz, 1H, H-1a”*), 4.32 (dd, J = 9.8, 2.9 Hz, 1H, 
H-5), 4.21 (d, J = 11.3 Hz, 1H, H-1b”*), 3.93 (dt, J = 10.3, 4.3 Hz, 1H, H-1’), 3.58 (d, J 
= 2.6 Hz, 1H, H-6), 1.49 (s, 3H, H-1), 1.29 (s, 3H, H-1); 13C NMR (100 MHz, CDCl3, 
δ/ppm): 147.9 (C-3a’’’#), 147.2 (C-7a’’’#), 136.8 (C-1”), 129.9 (C-5’’’), 128.5 (C-2”, C-
6”), 128.1 (C-4”), 127.9 (C-3”, C-5”), 121.6 (C-4’’’), 111.7 (C-2), 108.5 (C-6’’’), 108.2 
(C-7’’’), 105.1 (C-2’’’), 101.2 (C-3a), 81.5 (C-6), 81.4 (C-6a), 81.2 (C-5), 78.9 (C-2’), 
72.2 (C-1a”/b”), 42.8 (C-1’), 26.7 (C-1), 26.0 
15
s
found 443.1559; M/z (%): 443.1559 (100), 440.9774
4
  
 
Assignments denoted by * and # are interch
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6.3.5. 6-((1R)-1-{(3aR,5R,6R,6aR)-2,2-Dimethyl-6-
[(phenylmethyl)oxy]tetrahydrofuro[2,3-d][1,3]dioxol-5-yl}-2-nitroethyl)-2,3-
dihydro-1,4-benzodioxine 119 
 
O
O
O
O2N
O
O
O
3a
6a6
5
1'
2'
5'''
7'''2'''
4a'''
3''' 8a''' 8'''
119
1a"
1b"1"2"
3"
4" 5"
6"
 
 
Clear oil ( 0.25 g, 0.55 mmol, 48%) for the rhodium-catalyzed conjugate addition.  
Rf: 0.33 (25% AcOEt/hexane); [α]D: –36.5 (c 2.0, CHCl3, 22 °C); 1H NMR (300 MHz, 
CDCl3, δ/ppm): 7.38-7.22 (m, 5H, H-2”–H-6”), 6.78-6.74 (m, 2H, H-2’’’, H-6’’’), 6.70-
6.64 (m, 1H, H-5’’’), 5.93 (d, J = 3.7 Hz, 1H, H-3a), 4.93 (dd, J = 12.7, 4.4 Hz, 1H, H-
2’), 4.65 (dd, J = 12.7, 10.9 Hz, 1H, H-2’), 4.55 (d, J = 3.8 Hz, 1H, H-6a), 4.46 (d, J = 
11.2 Hz, 1H, H-1a”*), 4.32 (dd, J = 10.1, 2.9 Hz, 1H, H-5), 4.20 (d, J = 11.3 Hz, 1H, H-
1b”*), 4.19 (s, 4H, H-7’’’, H-8’’’), 3.92 (dt, J = 10.5, 4.4 Hz, 1H, H-1’), 3.56 (d, J = 2.9 
Hz, 1H, H-6), 1.49 (s, 3H, H-1), 1.29 (s, 3H, H-1); 13C NMR (100 MHz, CDCl3, δ/ppm): 
143.5 (C-4a’’’#), 143.2 (C-8a’’’#), 136.8 (C-1’’’), 129.4 (C-1”), 128.4 (C-2”, C-6”), 127.9 
(C-4”), 127.8 (C-3”, C-5”), 121.2 (C-8’’’), 117.4 (C-5’’’), 116.5 (C-7’’’), 111.6 (C-2), 
105.0 (C-3a), 81.4 (C-6), 81.3 (C-6a), 81.1 (C-5), 78.7 (C-2’), 72.0 (C-1a”/b”), 64
2
1
1
      
.1 (C-
’’’, C-3’’’), 42.2 (C-1’), 26.6 (C-1), 25.9 (C-1); IR (υ/cm-1): 2934 (w, C-H stretch), 
590 (C=C stretch), 1550 (s, N-O stretch), 1376 (m, C-H bend), 1287 (s, C-C stretch), 
H27O8N 457.1737 found 457.1715; 
/z (%): 457.1715 (100), 452.9779 (7), 447.9720 (7), 441.0068 (6), 431.9767 (8). 
 
2
1
1067 (s, C-O stretch); HRMS (EI): calculated for C24
M
 
Assignments denoted by * and # are interchangeable 
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6.3.6. (3aR,5R,6R,6aR)-2,2-Dimethyl-5-{(1R)-2-nitro-1-[3,4,5-
tris(methyloxy)phenyl]ethyl}-6-[(phenylmethyl)oxy]tetrahydrofuro[2,3-
d][1,3]dioxole 120 
 
O
O
O
O
3a
6a6
5
1a"
1b"
120
1"
2"
3"
4" 5"
6"
O2N
1'
2'
1'''2'''
3''' 6'''
2 1
1
MeO
4''' 5'''MeO
OMe
 
 
White oil (0.20 g, 0.41 mmol, 38%) for the rhodium-catalyzed conjugate addition.  Rf: 
0.47, (25% AcOEt/hexane); [α]D: –36.2 (c 1.9, CHCl3, 22 °C); 1H NMR (300 MHz, 
CDCl3, δ/ppm): 7.44-7.23 (m, 5H, H-2”–H-6”), 6.41 (s, 2H, H-2’’’, H-6’’’), 5.97 (d, J = 
3.7 Hz, 1H, H-3a), 5.01 (dd, J = 12.9, 4.4 Hz, 1H, 2’), 4.72 (dd, J = 12.9, 10.7 Hz, 1H, 
H-2’), 4.58 (d, J = 3.9 Hz, 1H, H-6a), 4.58 (d, J = 11.6 Hz, 1H, H-1a”*), 4.37 (dd, J = 
9.5, 2.6 Hz, 1H, H-5), 4.21 (d, J = 11.7 Hz, 1H, H-1b”*), 4.00 (dt, J = 10.4, 4.4 Hz, 1H, 
H-1’), 3.82 (s, 3H, OMe at C-4’’’), 3.69 (s, 6H, OMe at C-3’’’, C-5’’’), 3.62 (d, J = 2.6 
Hz, 1H, H-6), 1.51 (s, 3H, H-1), 1.32 (s, 1H, H-1); 13C NMR (100 MHz, CDCl3, δ/ppm): 
153.4 (C-3’’’, C-5’’’), 137.7 (C-4’’’), 137.1 (C-1’’’), 132.2 (C-1”), 128.5 (C-2”, C-6”), 
127.9 (C-4”), 126.9 (C-3”, C-5”), 111.7 (C-2), 105.2 (C-2’’’, C-6’’’), 105.1 (C-3a), 81.9 
(C-6), 81.5 (C-6a), 81.2 (C-5), 78.7 (C-2’), 71.9 (C-1a”/b”), 60.8 (OMe at C-4’’’), 56.1 
(OMe at C-3’’’, C-5’’’), 43.4 (C-1’), 26.7 (C-1), 26.0 (C-1); IR (υ/cm-1): 2930 (w, C-H 
tretch), 1591 (s, N-O stretch), 1350 (m, C-H bend), 1243 (s, C-C stretch), 1164 (m, C-C 
tretch), 1072, 994 (s, C-O stretch); HRMS (EI): calculated for C23H25O8N 489.1998 
85.9654 (1), 478.9718 (4), 474.1570 (6), 
72.0605 (1), 467.9872 (1). 
 
ents denoted by * are interchangeable 
 
s
s
found 489.1985; M/z (%): 489.1985 (100), 4
4
 
Assignm
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 104
.4.1. (2S,3R,4R,5R)-4-(Benzyloxy)-2-methoxy-5-((R)-2-nitro-1-phenylethyl)-
tetrahydrofuran-3-ol 125 
 
6.4. Experimental work pertaining to chapter 4 
 
6
O
OH
OMe
O
1
23
4
1a"
1b"
125
1a
1"2"
3"
4" 5"
6"
O2N
1'
2'
1'''2'''
3'''
4''' 5'''
6'''
ff the resin with methanol and evaporated solvent.  
repared a column using neutral alumina with 30% AcOEt/hexane.  Afforded a pale 
28.1 (C-3’’’, C-5’’’), 127.8 (C-4’’’), 127.8 (C-4”), 127.7 (C-3”, C-
”), 102.5 (C-1), 83.4 (C-3), 80.1 (C-2), 78.8 (C-2’), 75.3 (C-4) , 71.8 (C-1a”/b”), 56.1 
Assignments denoted by * are interchangeable 
 
 
 
To a stirring mixture of compound 117 (0.49 g, 1.22 mmol, 1 equiv.) in MeOH ( 15 cm3) 
was added Dowex H+ resin (1.51 g, 3 × mass of starting material).  Allowed reaction 
mixture to stir at room temperature under an atmosphere of nitrogen for 72 hours.  
Monitored reaction by TLC.  Filtered o
P
yellow oil (0.23 g, 0.62 mmol, 80%).   
 
Rf: 0.25, (30% AcOEt/hexane); 1H NMR (300 MHz, CDCl3, δ/ppm): 7.58-6.84 (m, 10H, 
H-2”–H-6”, H-2”’–H-6”’), 5.04 (d, J = 4.4 Hz, 1H, H-1), 4.91 (dd, J = 12.7, 5.1 Hz, 1H, 
H-2’), 4.61 (dd, J = 12.7, 9.8 Hz, 1H, H-2’), 4.41 (d, J = 11.7 Hz, 1H, H-1a”*), 4.36 (d, J 
= 4.0 Hz, 1H, H-2), 4.12 (d, J = 11.5 Hz, 1H, H-1b”*), 4.16-4.09 (m, 1H, H-4), 3.48 (dd, 
J = 4.0, 1.4 Hz, 1H, H-3), 3.44 (s, 3H, H-1a), 2.78 (d, J = 3.9 Hz, 1H, OH at C-2); 13C 
NMR (100 MHz, CDCl3, δ/ppm): 137.2 (C-1’’’), 136.8 (C-1”), 128.7 (C-2’’’,C-6’’’), 
128.3 (C-2”, C-6”), 1
5
(C-1a), 43.4 (C-1’). 
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APPENDIX 
 
X-Ray crystallographical data for (1R)-2-nitro-1-phenylethyl]-tetrahydrofuro-
dioxole 117 
 
O
O
O
O2N
BnO
Ph
117  
 
 
 
Table 1.  Crystal data and structure refinement for 117. 
Identification code  117 
Empirical formula  C22 H25 N O6 
Formula weight  399.43 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P212121 
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Unit cell dimensions a = 8.90410(10) Å α= 90°. 
 b = 10.2774(2) Å β= 90°. 
 c = 22.5111(4) Å γ = 90°. 
Volume 2060.01(6) Å3 
Z 4 
Density (calculated) 1.288 Mg/m3 
Absorption coefficient 0.094 mm-1 
F(000) 848 
Crystal size 0.45 x 0.39 x 0.14 mm3 
Theta range for data collection 1.81 to 28.00°. 
Index ranges -11<=h<=11, -13<=k<=13, -29<=l<=29 
Reflections collected 46960 
Independent reflections 2824 [R(int) = 0.0367] 
Completeness to theta = 28.00° 100.0 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2824 / 0 / 264 
Goodness-of-fit on F2 1.062 
Final R indices [I>2sigma(I)] R1 = 0.0327, wR2 = 0.0846 
R indices (all data) R1 = 0.0378, wR2 = 0.0876 
Absolute structure parameter -10(10) 
Largest diff. peak and hole 0.199 and -0.165 e.Å-3 
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Table 2.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for 117.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
C(1) 3425(2) 1309(2) -124(1) 33(1) 
C(2) 4638(2) 1226(2) 355(1) 31(1) 
C(3) 3775(2) 1348(2) 935(1) 29(1) 
C(4) 2296(2) 700(2) 765(1) 28(1) 
C(5) 4922(2) -480(2) -303(1) 38(1) 
C(6) 4384(5) -1863(2) -289(1) 87(1) 
C(7) 6302(3) -283(3) -677(1) 65(1) 
C(8) 4757(2) 3207(2) 1409(1) 55(1) 
C(9) 4523(2) 4630(2) 1527(1) 38(1) 
C(10) 3814(3) 5035(2) 2038(1) 47(1) 
C(11) 3665(3) 6346(2) 2160(1) 57(1) 
C(12) 4243(3) 7257(2) 1778(1) 55(1) 
C(13) 4958(2) 6871(2) 1270(1) 51(1) 
C(14) 5093(2) 5563(2) 1140(1) 45(1) 
C(15) 913(2) 1051(2) 1130(1) 28(1) 
C(16) -408(2) 281(2) 875(1) 34(1) 
C(17) 1162(2) 779(2) 1787(1) 30(1) 
C(18) 1202(2) -470(2) 2012(1) 41(1) 
C(19) 1442(2) -680(2) 2616(1) 52(1) 
C(20) 1644(2) 358(3) 2991(1) 56(1) 
C(21) 1612(3) 1598(3) 2772(1) 58(1) 
C(22) 1372(2) 1820(2) 2172(1) 43(1) 
N(1) -1796(2) 491(2) 1232(1) 37(1) 
O(1) 2029(1) 1103(1) 161(1) 32(1) 
O(2) 3758(2) 327(2) -524(1) 56(1) 
O(3) 5197(1) -66(1) 293(1) 35(1) 
O(4) 3531(1) 2683(1) 1068(1) 33(1) 
O(5) -2470(2) -454(2) 1419(1) 61(1) 
O(6) -2179(2) 1614(2) 1319(1) 55(1) 
________________________________________________________________________________
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Table 3.   Bond lengths [Å] and angles [°] for 117. 
_____________________________________________________ 
C(1)-O(2)  1.384(2) 
C(1)-O(1)  1.415(2) 
C(1)-C(2)  1.529(2) 
C(1)-H(1)  1.0000 
C(2)-O(3)  1.426(2) 
C(2)-C(3)  1.521(2) 
C(2)-H(2)  1.0000 
C(3)-O(4)  1.421(2) 
C(3)-C(4)  1.526(2) 
C(3)-H(3)  1.0000 
C(4)-O(1)  1.4413(19) 
C(4)-C(15)  1.524(2) 
C(4)-H(4)  1.0000 
C(5)-O(2)  1.417(2) 
C(5)-O(3)  1.427(2) 
C(5)-C(6)  1.500(3) 
C(5)-C(7)  1.504(3) 
C(6)-H(6A)  0.9800 
C(6)-H(6B)  0.9800 
C(6)-H(6C)  0.9800 
C(7)-H(7A)  0.9800 
C(7)-H(7B)  0.9800 
C(7)-H(7C)  0.9800 
C(8)-O(4)  1.439(2) 
C(8)-C(9)  1.501(3) 
C(8)-H(8A)  0.9900 
C(8)-H(8B)  0.9900 
C(9)-C(10)  1.377(3) 
C(9)-C(14)  1.391(3) 
C(10)-C(11)  1.382(3) 
C(10)-H(10)  0.9500 
C(11)-C(12)  1.371(3) 
C(11)-H(11)  0.9500 
C(12)-C(13)  1.368(3) 
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C(12)-H(12)  0.9500 
C(13)-C(14)  1.380(3) 
C(13)-H(13)  0.9500 
C(14)-H(14)  0.9500 
C(15)-C(17)  1.521(2) 
C(15)-C(16)  1.529(2) 
C(15)-H(15)  1.0000 
C(16)-N(1)  1.489(2) 
C(16)-H(16A)  0.9900 
C(16)-H(16B)  0.9900 
C(17)-C(18)  1.380(3) 
C(17)-C(22)  1.390(2) 
C(18)-C(19)  1.392(3) 
C(18)-H(18)  0.9500 
C(19)-C(20)  1.372(3) 
C(19)-H(19)  0.9500 
C(20)-C(21)  1.367(4) 
C(20)-H(20)  0.9500 
C(21)-C(22)  1.386(3) 
C(21)-H(21)  0.9500 
C(22)-H(22)  0.9500 
N(1)-O(5)  1.217(2) 
N(1)-O(6)  1.219(2) 
 
O(2)-C(1)-O(1) 111.93(15) 
O(2)-C(1)-C(2) 105.46(14) 
O(1)-C(1)-C(2) 106.97(12) 
O(2)-C(1)-H(1) 110.8 
O(1)-C(1)-H(1) 110.8 
C(2)-C(1)-H(1) 110.8 
O(3)-C(2)-C(3) 109.72(13) 
O(3)-C(2)-C(1) 103.27(13) 
C(3)-C(2)-C(1) 104.21(13) 
O(3)-C(2)-H(2) 113.0 
C(3)-C(2)-H(2) 113.0 
C(1)-C(2)-H(2) 113.0 
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O(4)-C(3)-C(2) 109.75(14) 
O(4)-C(3)-C(4) 110.01(13) 
C(2)-C(3)-C(4) 100.57(12) 
O(4)-C(3)-H(3) 112.0 
C(2)-C(3)-H(3) 112.0 
C(4)-C(3)-H(3) 112.0 
O(1)-C(4)-C(15) 107.95(12) 
O(1)-C(4)-C(3) 104.73(13) 
C(15)-C(4)-C(3) 117.29(13) 
O(1)-C(4)-H(4) 108.9 
C(15)-C(4)-H(4) 108.9 
C(3)-C(4)-H(4) 108.9 
O(2)-C(5)-O(3) 106.35(13) 
O(2)-C(5)-C(6) 109.1(2) 
O(3)-C(5)-C(6) 108.54(17) 
O(2)-C(5)-C(7) 108.80(17) 
O(3)-C(5)-C(7) 110.23(18) 
C(6)-C(5)-C(7) 113.5(2) 
C(5)-C(6)-H(6A) 109.5 
C(5)-C(6)-H(6B) 109.5 
H(6A)-C(6)-H(6B) 109.5 
C(5)-C(6)-H(6C) 109.5 
H(6A)-C(6)-H(6C) 109.5 
H(6B)-C(6)-H(6C) 109.5 
C(5)-C(7)-H(7A) 109.5 
C(5)-C(7)-H(7B) 109.5 
H(7A)-C(7)-H(7B) 109.5 
C(5)-C(7)-H(7C) 109.5 
H(7A)-C(7)-H(7C) 109.5 
H(7B)-C(7)-H(7C) 109.5 
O(4)-C(8)-C(9) 110.67(15) 
O(4)-C(8)-H(8A) 109.5 
C(9)-C(8)-H(8A) 109.5 
O(4)-C(8)-H(8B) 109.5 
C(9)-C(8)-H(8B) 109.5 
H(8A)-C(8)-H(8B) 108.1 
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C(10)-C(9)-C(14) 118.79(19) 
C(10)-C(9)-C(8) 120.4(2) 
C(14)-C(9)-C(8) 120.7(2) 
C(9)-C(10)-C(11) 120.3(2) 
C(9)-C(10)-H(10) 119.8 
C(11)-C(10)-H(10) 119.8 
C(12)-C(11)-C(10) 120.4(2) 
C(12)-C(11)-H(11) 119.8 
C(10)-C(11)-H(11) 119.8 
C(13)-C(12)-C(11) 120.0(2) 
C(13)-C(12)-H(12) 120.0 
C(11)-C(12)-H(12) 120.0 
C(12)-C(13)-C(14) 120.0(2) 
C(12)-C(13)-H(13) 120.0 
C(14)-C(13)-H(13) 120.0 
C(13)-C(14)-C(9) 120.46(19) 
C(13)-C(14)-H(14) 119.8 
C(9)-C(14)-H(14) 119.8 
C(17)-C(15)-C(4) 111.33(13) 
C(17)-C(15)-C(16) 112.45(14) 
C(4)-C(15)-C(16) 107.23(12) 
C(17)-C(15)-H(15) 108.6 
C(4)-C(15)-H(15) 108.6 
C(16)-C(15)-H(15) 108.6 
N(1)-C(16)-C(15) 111.12(13) 
N(1)-C(16)-H(16A) 109.4 
C(15)-C(16)-H(16A) 109.4 
N(1)-C(16)-H(16B) 109.4 
C(15)-C(16)-H(16B) 109.4 
H(16A)-C(16)-H(16B) 108.0 
C(18)-C(17)-C(22) 118.89(16) 
C(18)-C(17)-C(15) 122.14(15) 
C(22)-C(17)-C(15) 118.96(16) 
C(17)-C(18)-C(19) 120.43(19) 
C(17)-C(18)-H(18) 119.8 
C(19)-C(18)-H(18) 119.8 
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C(20)-C(19)-C(18) 120.0(2) 
C(20)-C(19)-H(19) 120.0 
C(18)-C(19)-H(19) 120.0 
C(21)-C(20)-C(19) 119.97(18) 
C(21)-C(20)-H(20) 120.0 
C(19)-C(20)-H(20) 120.0 
C(20)-C(21)-C(22) 120.6(2) 
C(20)-C(21)-H(21) 119.7 
C(22)-C(21)-H(21) 119.7 
C(21)-C(22)-C(17) 120.1(2) 
C(21)-C(22)-H(22) 120.0 
C(17)-C(22)-H(22) 120.0 
O(5)-N(1)-O(6) 124.21(17) 
O(5)-N(1)-C(16) 118.66(17) 
O(6)-N(1)-C(16) 117.13(15) 
C(1)-O(1)-C(4) 109.05(12) 
C(1)-O(2)-C(5) 110.78(13) 
C(2)-O(3)-C(5) 108.04(13) 
C(3)-O(4)-C(8) 110.91(13) 
_____________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
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Table 4.   Anisotropic displacement parameters (Å2x 103)for 117.  The anisotropic 
displacement factor exponent takes the form: -2π2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
C(1) 30(1)  39(1) 28(1)  6(1) 4(1)  4(1) 
C(2) 26(1)  31(1) 35(1)  -1(1) 2(1)  2(1) 
C(3) 27(1)  32(1) 27(1)  -2(1) -2(1)  6(1) 
C(4) 28(1)  32(1) 24(1)  -3(1) 1(1)  3(1) 
C(5) 42(1)  41(1) 30(1)  -3(1) 10(1)  5(1) 
C(6) 156(3)  52(1) 54(1)  -12(1) 4(2)  -31(2) 
C(7) 44(1)  102(2) 50(1)  3(1) 19(1)  16(1) 
C(8) 41(1)  48(1) 75(1)  -23(1) -30(1)  12(1) 
C(9) 27(1)  42(1) 44(1)  -14(1) -13(1)  3(1) 
C(10) 48(1)  51(1) 41(1)  -6(1) 0(1)  -8(1) 
C(11) 58(1)  63(1) 49(1)  -25(1) 6(1)  2(1) 
C(12) 51(1)  45(1) 68(1)  -18(1) -13(1)  2(1) 
C(13) 42(1)  55(1) 56(1)  4(1) -10(1)  -11(1) 
C(14) 30(1)  67(1) 37(1)  -10(1) -3(1)  -2(1) 
C(15) 26(1)  29(1) 28(1)  -2(1) 2(1)  3(1) 
C(16) 28(1)  41(1) 34(1)  -5(1) 1(1)  2(1) 
C(17) 23(1)  40(1) 27(1)  -3(1) 4(1)  3(1) 
C(18) 42(1)  44(1) 38(1)  3(1) 1(1)  7(1) 
C(19) 42(1)  67(1) 46(1)  20(1) 2(1)  11(1) 
C(20) 39(1)  99(2) 28(1)  5(1) 1(1)  8(1) 
C(21) 60(1)  79(2) 34(1)  -17(1) 0(1)  -2(1) 
C(22) 47(1)  48(1) 34(1)  -8(1) 4(1)  1(1) 
N(1) 27(1)  50(1) 35(1)  8(1) -1(1)  3(1) 
O(1) 26(1)  47(1) 24(1)  -1(1) -1(1)  2(1) 
O(2) 46(1)  89(1) 33(1)  -21(1) -6(1)  25(1) 
O(3) 36(1)  38(1) 32(1)  -4(1) 1(1)  12(1) 
O(4) 27(1)  34(1) 37(1)  -9(1) -7(1)  5(1) 
O(5) 46(1)  70(1) 65(1)  22(1) 5(1)  -14(1) 
O(6) 44(1)  60(1) 60(1)  10(1) 15(1)  21(1) 
______________________________________________________________________________
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Table 5.   Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) 
for 117. 
________________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________________ 
 
H(1) 3446 2178 -324 39 
H(2) 5436 1903 309 37 
H(3) 4288 883 1269 35 
H(4) 2433 -266 773 33 
H(6A) 3492 -1926 -36 131 
H(6B) 5179 -2423 -130 131 
H(6C) 4131 -2143 -693 131 
H(7A) 6085 -530 -1088 98 
H(7B) 7120 -826 -523 98 
H(7C) 6602 634 -663 98 
H(8A) 5709 3081 1189 65 
H(8B) 4836 2735 1791 65 
H(10) 3425 4410 2308 56 
H(11) 3158 6618 2510 68 
H(12) 4147 8157 1867 66 
H(13) 5362 7502 1006 61 
H(14) 5579 5299 784 54 
H(15) 705 2000 1079 33 
H(16A) -589 556 460 41 
H(16B) -157 -657 872 41 
H(18) 1066 -1191 1754 50 
H(19) 1464 -1542 2768 62 
H(20) 1807 215 3403 67 
H(21) 1756 2314 3033 69 
H(22) 1352 2685 2024 52 
________________________________________________________________________________
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Table 6.  Torsion angles [°] for 117. 
________________________________________________________________ 
O(2)-C(1)-C(2)-O(3) -20.37(17) 
O(1)-C(1)-C(2)-O(3) 98.95(15) 
O(2)-C(1)-C(2)-C(3) -135.03(15) 
O(1)-C(1)-C(2)-C(3) -15.72(17) 
O(3)-C(2)-C(3)-O(4) 166.07(13) 
C(1)-C(2)-C(3)-O(4) -83.92(16) 
O(3)-C(2)-C(3)-C(4) -78.03(15) 
C(1)-C(2)-C(3)-C(4) 31.99(16) 
O(4)-C(3)-C(4)-O(1) 77.85(15) 
C(2)-C(3)-C(4)-O(1) -37.86(15) 
O(4)-C(3)-C(4)-C(15) -41.77(19) 
C(2)-C(3)-C(4)-C(15) -157.48(14) 
O(4)-C(8)-C(9)-C(10) 92.3(2) 
O(4)-C(8)-C(9)-C(14) -91.5(2) 
C(14)-C(9)-C(10)-C(11) 0.5(3) 
C(8)-C(9)-C(10)-C(11) 176.8(2) 
C(9)-C(10)-C(11)-C(12) -1.1(4) 
C(10)-C(11)-C(12)-C(13) 0.7(4) 
C(11)-C(12)-C(13)-C(14) 0.2(3) 
C(12)-C(13)-C(14)-C(9) -0.8(3) 
C(10)-C(9)-C(14)-C(13) 0.5(3) 
C(8)-C(9)-C(14)-C(13) -175.82(18) 
O(1)-C(4)-C(15)-C(17) -174.41(13) 
C(3)-C(4)-C(15)-C(17) -56.51(19) 
O(1)-C(4)-C(15)-C(16) 62.20(17) 
C(3)-C(4)-C(15)-C(16) -179.90(14) 
C(17)-C(15)-C(16)-N(1) 53.37(19) 
C(4)-C(15)-C(16)-N(1) 176.06(13) 
C(4)-C(15)-C(17)-C(18) -72.6(2) 
C(16)-C(15)-C(17)-C(18) 47.8(2) 
C(4)-C(15)-C(17)-C(22) 106.65(18) 
C(16)-C(15)-C(17)-C(22) -133.00(17) 
C(22)-C(17)-C(18)-C(19) 0.4(3) 
C(15)-C(17)-C(18)-C(19) 179.61(17) 
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C(17)-C(18)-C(19)-C(20) -0.2(3) 
C(18)-C(19)-C(20)-C(21) -0.1(3) 
C(19)-C(20)-C(21)-C(22) 0.2(4) 
C(20)-C(21)-C(22)-C(17) 0.0(4) 
C(18)-C(17)-C(22)-C(21) -0.3(3) 
C(15)-C(17)-C(22)-C(21) -179.51(19) 
C(15)-C(16)-N(1)-O(5) -126.75(18) 
C(15)-C(16)-N(1)-O(6) 53.1(2) 
O(2)-C(1)-O(1)-C(4) 106.30(15) 
C(2)-C(1)-O(1)-C(4) -8.74(18) 
C(15)-C(4)-O(1)-C(1) 155.55(14) 
C(3)-C(4)-O(1)-C(1) 29.85(17) 
O(1)-C(1)-O(2)-C(5) -107.63(17) 
C(2)-C(1)-O(2)-C(5) 8.3(2) 
O(3)-C(5)-O(2)-C(1) 7.1(2) 
C(6)-C(5)-O(2)-C(1) 123.97(19) 
C(7)-C(5)-O(2)-C(1) -111.7(2) 
C(3)-C(2)-O(3)-C(5) 135.69(14) 
C(1)-C(2)-O(3)-C(5) 25.05(16) 
O(2)-C(5)-O(3)-C(2) -20.80(18) 
C(6)-C(5)-O(3)-C(2) -138.1(2) 
C(7)-C(5)-O(3)-C(2) 96.97(19) 
C(2)-C(3)-O(4)-C(8) -89.05(18) 
C(4)-C(3)-O(4)-C(8) 161.19(16) 
C(9)-C(8)-O(4)-C(3) 177.68(17) 
________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
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